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Abstract
In April and May of 2016, Norway confirmed two cases of chronic wasting disease (CWD) in a wild
reindeer and a wild moose, respectively. In the light of this emerging issue, the European Commission
requested EFSA to recommend surveillance activities and, if necessary, additional animal health
risk-based measures to prevent the introduction of the disease and the spread into/within the EU,
specifically Estonia, Finland, Iceland, Latvia, Lithuania, Norway, Poland and Sweden, and considering
seven wild, semidomesticated and farmed cervid species (Eurasian tundra reindeer, Finnish (Eurasian)
forest reindeer, moose, roe deer, white-tailed deer, red deer and fallow deer). It was also asked to
assess any new evidence on possible public health risks related to CWD. A 3-year surveillance system
is proposed, differing for farmed and wild or semidomesticated cervids, with a two-stage sampling
programme at the farm/geographically based population unit level (random sampling) and individual
level (convenience sampling targeting high-risk animals). The current derogations of Commission
Implementing Decision (EU) 2016/1918 present a risk of introduction of CWD into the EU. Measures to
prevent the spread of CWD within the EU are dependent upon the assumption that the disease is
already present; this is currently unknown. The measures listed are intended to contain (limit the
geographic extent of a focus) and/or to control (actively stabilise/reduce infection rates in an affected
herd or population) the disease where it occurs. With regard to the zoonotic potential, the human
species barrier for CWD prions does not appear to be absolute. These prions are present in the
skeletal muscle and other edible tissues, so humans may consume infected material in enzootic areas.
Epidemiological investigations carried out to date make no association between the occurrence of
sporadic Creutzfeldt–Jakob disease in humans and exposure to CWD prions.
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Summary
In April and May of 2016, Norway confirmed two cases of chronic wasting disease (CWD) in a wild
reindeer and a wild moose, respectively. This was the first time CWD had been detected in Europe and
the first natural case in reindeer in the world. In the light of the sensitivity of this emerging issue, the
European Food Safety Authority (EFSA) was asked by the European Commission to deliver its scientific
opinion by 31 December 2016 on the following Terms of Reference (ToRs): (1) to provide
recommendations on surveillance of cervid populations at the country level aimed at detecting CWD
and/or estimating the prevalence of CWD in Norway, Sweden, Finland, Iceland, Estonia, Latvia and
Poland, which are the European Union (EU) and European Economic Area (EEA) countries with
reindeer and/or moose populations, depending on the level of prevalence which is wished to be
detected; (2) has new evidence become available with regard to possible public health risks due to the
occurrence of CWD in cervids since the publication of the 2011 joint EFSA/ECDC opinion? Does the
natural exposure of consumers to cervid products originating from regions where CWD cases are
detected represent a risk for public health? (3) EFSA is asked to recommend, if necessary, additional
animal health risk-based measures to prevent the introduction of CWD into the EU cervid populations
and to prevent its spread within the EU.
It was agreed with the requestor to also include Lithuania in the mandate, and to consider the following
seven wild, semidomesticated and farmed cervids, namely Eurasian tundra reindeer (Rangifer tarandus
tarandus), Finnish (Eurasian) forest reindeer (Rangifer tarandus fennicus), moose (Eurasian/European
elk) (Alces alces alces), roe deer (Capreolus capreolus), white-tailed deer (Odocoileus virginianus), red
deer (Cervus elaphus) and fallow deer (Dama dama).
The data used in this assessment have been sourced via different literature searches, looking at the
new evidence from experimental studies examining the transmissibility of transmissible spongiform
encephalopathies (TSE) agents to humans, as well as the epidemiology, surveillance and control of
CWD. The figures on wild and hunted population abundance were obtained from different sources and
represent various methodologies used for census and estimates. Surveillance data in Europe in 2015
have been extracted from annual reports submitted by the Member States (MS) and from the
background information provided by the European Commission and included in the mandate.
It was agreed, due to limited time and resources, to carry out a qualitative evaluation by means of
literature reviews based on the knowledge and expertise of the Working Group (WG) members. The
experts in the WG selected relevant references starting from review papers, books chapters, non-peer-
review papers known by the experts themselves or retrieved through non-systematic searches until the
information of the subject was considered sufficient to undertake the assessment by the WG. The
literature search was used to support the expert review of these areas, and additional scientific
information known by the experts was also considered in the assessment.
The surveillance system proposed for the countries concerned is based on the experience of CWD
surveillance in North America and the knowledge of the different structures and management systems
of the cervid populations of some of the countries concerned, in particular Norway and Sweden. The
aims of the proposed surveillance system are to detect disease in countries where CWD has not yet
been detected using a predefined design prevalence and to estimate prevalence in areas where disease
has been detected. It is intended to overcome the shortcomings highlighted in the evaluation of the
previous surveillance programme implemented in Europe 2006–2010. A two-stage sampling programme
is proposed based on the application of random sampling at the first stage (for wild/semidomesticated
cervids the ‘primary sampling units’ (PSU) will correspond to geographical areas containing cervid
populations, whereas for farmed cervids they will correspond to farms) and the application of
convenience sampling of high-risk animals within PSU (found dead, hunted or slaughtered animals
considered not fit for human consumption, road/predator kills and animals killed because they are sick
or in poor body condition and not fit for human consumption) of any of the selected species at the
second stage.
With regard to the public health risks, there is currently no experimental model that encompasses
all the potential host and agent variability required to assess zoonotic potential directly for any animal
prion disease, including CWD. Although CWD has been experimentally transmitted to squirrel monkeys;
in vivo transmission of CWD to other animal models including macaques and humanised mice has not
yet been reported. CWD strains, their prevalence, host range and zoonotic potential remain
incompletely understood. All currently available data pertaining to host range and human risk are
derived from isolates obtained from North American cervid species, but preliminary evidence from the
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Norwegian CWD cases raises the possibility that European and North American isolates are different
from each other.
There is no evidence of an absolute species barrier between CWD-affected cervids and humans.
CWD prions are present in the skeletal muscle and other edible tissues, which means that humans
may consume infected material in enzootic areas. However, from the epidemiological investigations
carried out to date, no association has been made between the occurrence of sporadic Creutzfeldt–
Jakob disease (sCJD) in humans and exposure to CWD.
Since it was concluded that the most likely pathway of introduction of CWD into the EU is the
movement of live cervids, the current derogations of Article 2.2 of the Commission Implementing
Decision (EU) 2016/1918 present a risk of introduction of CWD into the EU. The probability of
introduction of CWD into and spread within the EU associated with the movement of live cervids for
direct slaughter is considered to be lower than situations in which live animals are translocated for
other purposes. Minimising movements of live cervids would reduce the probability of introduction of
CWD into the EU. The use of natural cervid urine lures is considered to increase the probability of
introduction of CWD into the EU. Compliance with recommendations included in awareness campaigns
targeting both local Norwegian hunters, and hunters visiting Norway from (and returning to) other
countries, would reduce the probability of introduction of CWD into the EU.
Measures to prevent the spread of CWD within the EU are dependent upon the assumption that the
disease is already present in some part of the EU territory. At the time of writing this opinion, this is
unknown. The uncertainties associated with the limited knowledge of the situation of CWD in the
countries concerned could render any of the recommended measures inadequate or insufficient.
Moreover, strategies to prevent the introduction and/or the spread of CWD must be based on a
combination of measures.
A list of measures has been included. Some aim to reduce animal-to-animal contact and lower
population densities; others relate to increasing the disease awareness among stakeholders, reducing
environmental contamination and developing contingency plans, including quarantine and other
measures in infected and management premises/areas. Specific prohibitions within Norway, affecting
silage, feed and lichen to prevent the spread of CWD, have been mentioned.
Additional activities have been recommended, such as reviewing the design of the surveillance
system after 1 year of implementation, conducting a risk assessment to estimate the likelihood of
introduction of CWD into the EU, collecting data on the cervid populations in Europe, implementing an
individual identification system and record-keeping of farmed and semidomesticated cervids together
with an ad hoc data collection system for surveillance. Any positive case detected through surveillance
should be genotyped and characterised by strain typing, with representative material archived for
future reference. It is also recommended that all or a representative subset of cervids tested negative
by surveillance are genotyped. Consideration is given to implementing surveillance programmes in
other MS.
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1. Introduction
1.1. Background and Terms of Reference as provided by the requestor
1.1.1. Previous opinions on zoonotic aspects of CWD and surveillance
The former Scientific Steering Committee of the European Commission (SSC)1 adopted on 6–7
March 2003 an opinion ‘on chronic wasting disease (CWD) and tissues that might carry a risk for
human and animal feed chains’. In summary, it highlighted that a risk of prion transmissions to
humans consuming products of CWD-affected cervids could not be excluded.
In its scientific opinion of 3 June 2004 on a surveillance programme for CWD in the European Union
(EU) (EFSA, 2004), the European Food Safety Authority (EFSA) stressed ‘a potential risk to consumers
if a transmissible spongiform encephalopathy (TSE) would be present in European cervids’. EFSA
further highlighted that ‘it might be prudent considering appropriate measures to reduce such a risk,
e.g. excluding tissues such as central nervous system (CNS) and lymphoid tissues from the human
food chain, which would greatly reduce any potential risk for consumers. However, it is stressed that
currently, no data regarding a risk of TSE infections from cervid products for humans are available’.
In its 2011 scientific opinion on possible associations between TSEs in animals and humans (EFSA
BIOHAZ Panel (2011), EFSA concluded regarding CWD that, although CWD agents have failed to induce
disease in transgenic mice expressing human prion protein (PrP), experimental transmission to certain
non-human primate species has been reported. EFSA also mentioned ongoing experiments to assess
the zoonotic potential of CWD strains in primate models.
The SSC Opinion of 6–7 March 2003 also recommended the instigation of a surveillance programme
for TSE in cervids in the EU. As a result, the Commission asked EFSA for recommendations concerning
such surveillance, and EFSA recommended in its opinion of June 2004 to initiate an EU-wide
experimental screening, targeting at-risk groups of animals.
On that basis, a survey on CWD in the EU was launched by Commission Decision 2007/182/EC2 and
implemented between 2007 and 2010. In this framework, more than 13,000 samples were collected from
21 Member States (MS) and Norway, mainly from red deer and white-tailed deer (the survey also included
74 samples from reindeer), without any sample found positive to TSE. Therefore, EFSA concluded in 2010
that, while occurrences of cases of TSEs in cervids in the EU could not be excluded, especially in remote
and presently unsampled geographical areas, there was no cervid TSE epidemic in the EU.
In mid-March 2016, a sick animal was observed during an exercise of identification and registration
of wild reindeers (Rangifer tarandus) by the Norwegian Institute for Nature Research, in the locality of
Laerdal. The animal subsequently died and its carcass was sent to the Norwegian Veterinary Institute
for necropsy. The necropsy included testing for TSE. On 4 April 2016, the Norwegian NRL for TSEs
confirmed the presence of TSE by enzyme-linked immunosorbent assay (ELISA), western blot (WB)
and immunohistochemistry (IHC). On 7 April 2016, the European Reference laboratory (EURL) for TSE
confirmed that the samples received were strongly positive for TSE and were presumptive for CWD.
On 27 April 2016, the International Organization of Animal Health (OIE) Reference Laboratory for CWD
in Canada (Canadian Food Inspection Agency) confirmed the CWD-positive diagnosis, noting that the
sample was consistent with CWD in farmed and wild cervids in Canada, and reindeer experimentally
infected with CWD by the oral route.
On 25 May 2016, a second case of CWD was confirmed in Norway, this time in a wild moose, in the
locality of Selbu. The moose (Alces alces) was a young adult and pregnant female, which was killed
due to abnormal behaviour. The animal was dehydrated, cachectic and had increased urination. It was
found in Selbu in south Norway. The Norwegian NRL for TSE performed ELISA and WB, which were
both positive.
Following these cases, Norway has expanded its surveillance of cervids for TSEs. Norway’s objective
is to test those cervids found sick or that died but were not slaughtered for human consumption. In
addition, the Norwegian authorities encourage hunters in the two concerned regions to bring heads of
animals killed during the hunting season to control points in view of TSE sampling and testing.
Furthermore, Norway plans to start a surveillance programme for farmed reindeer, during the
slaughter season which starts in September 2016.
1 https://ec.europa.eu/food/sites/food/files/safety/docs/sci-com_ssc_out323_en.pdf
2 Commission Decision of 19 March 2007 on a survey for chronic wasting disease in cervids. OJ L 84/37 24.3.2007.
Chronic wasting disease (CWD) in cervids
www.efsa.europa.eu/efsajournal 6 EFSA Journal 2017;15(1):4667
Additional information provided by the MS at request of the Commission included the UK informing
the Commission on an updated qualitative risk assessment (RA) on the risk that CWD is being
introduced into Great Britain (GB). The assessment is available at: https://www.gov.uk/govemment/
up1oads/svstem/uploads/attachmentdata/file/514401/qra-chronic-wasting-disease.pdf
1.1.2. Terms of Reference
EFSA is requested by the European Commission to provide a scientific opinion on the following
questions:
1) EFSA is asked to provide recommendations on surveillance of the cervid populations at the
country level aimed at detecting CWD and/or estimating the prevalence of CWD in Norway,
Sweden, Finland, Iceland, Estonia, Latvia and Poland, which are the EU and EEA countries
with reindeer and/or moose populations, depending on the level of prevalence which is
wished to be detected.
2) Has new evidence become available with regard to possible public health risks due to the
occurrence of CWD in cervids since the publication of the 2011 joint EFSA/ECDC opinion?
Does the natural exposure of consumers to cervid products originating from regions where
CWD cases are detected represent a risk for public health?
3) EFSA is asked to recommend, if necessary, additional animal health risk-based measures to
prevent the introduction of CWD into the EU cervid populations and to prevent its spread
within the EU?
4) Are the conclusions and recommendations in the EFSA opinion of June 2004 on diagnostic
methods for CWD still valid? If not, an update should be provided.
5) EFSA is asked to update the conclusions of the 2010 EFSA opinion on the results of the EU
survey on CWD in cervids, as regards the occurrence of CWD in the cervid population in the EU.
1.2. Interpretation of the Terms of Reference (if appropriate)
In the light of the sensitivity of this emerging issue, EFSA was asked by the European Commission
to deliver its scientific opinion as soon as possible and according to the following schedule:
• EFSA is asked to provide its scientific opinion on the Terms of Reference No 1 (surveillance), 2
(public health) and 3 (risk mitigation measures) by 31 December 2016;
• EFSA is asked to provide its scientific opinion on the Terms of Reference No 4 (diagnostic of
CWD) and 5 (review of 2010 EFSA opinion) by 31 December 2017.
It was agreed with the requestor to include Lithuania in the scope of the mandate due to the
significant moose population in this country and its geographical location. Thus, the countries considered
in this assessment are: Estonia, Finland, Iceland, Latvia, Lithuania, Norway, Poland and Sweden.
Taxonomically, cervids belong to the family Cervidae. The family Cervidae has two subfamilies:
Cervinae and Capreolinae (or Odocoileinae).
Since there may be confusion and misunderstanding regarding the common names on cervid
species (e.g. ‘Eurasian elk’ is the moose in Europe (Alces alces alces) but ‘North American elk’ (wapiti;
Cervus elaphus nelsoni) are more equivalent to European ‘red deer’, etc.), it is necessary to refer to
their Latin names. The cervid species below are referenced by common names hereafter. Unless
preceded by a descriptor (e.g. ‘red’, ‘mule’) or otherwise denoted, the term ‘deer’ refers generically to
animals of North American species in the genus Odocoileus.
The following species or subspecies in Europe are referred to in this report:
• Subfamily Capreolinae:
– Eurasian tundra reindeer (Rangifer tarandus tarandus)
– Finnish (Eurasian) forest reindeer (Rangifer tarandus fennicus)
– Moose (or Eurasian/European elk) (Alces alces alces).
– Roe deer (Capreolus capreolus)
– White-tailed deer (Odocoileus virginianus)
• Subfamily Cervinae:
– Red deer (Cervus elaphus)
– Fallow deer (Dama dama).
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For the countries of interest for this report, the management of cervid populations are considered
for three different systems (where applicable): (a) wild cervid populations (i.e. all species, free ranging,
no private owners); (b) semidomesticated reindeer, which constitutes those reindeer that are herded
(i.e. Eurasian tundra reindeer); and (c) farmed cervids (i.e. red deer and fallow deer, held in fixed
enclosures all year around and throughout their lifetime). In contrast to cervids in all these three
management systems, cervids in parks and zoos are not raised for human consumption. However, such
cervids have, in practical terms, a management system that is similar to that of farmed cervids and will
thus not be dealt with separately in this report. These three management systems are considered to be
of significant potential relevance to the epidemiology of CWD, and thus to surveillance and control.
1.3. Additional information (if appropriate)
Additional background information contained in the mandate, namely, current measures and import
data on cervid meat, has been included in Appendix A.
2. Data and methodologies
2.1. Data
The data used in parts of Section 3.1 and in Section 3.2 have been sourced via different literature
searches, looking at new evidence on the experimental studies showing the transmissibility of the TSE
agents to humans, as well the epidemiology, surveillance and control of CWD, as described in
Section 2.2. Additional data have been extracted from scientific papers that were out of the scope of
the search due to the specific subject.
The figures on population abundance included in Section 3.3.4 were obtained from different sources
and represent various methodologies used for census and estimates of wildlife population. Additionally,
some of the data presented is several years old since more recent data could not be obtained, and the
actual population sizes may have changed since the data were recorded. Therefore, the population data
presented may be incomplete or outdated, reflecting the stated difficulties. Hunting statistics presented
in the table below are mostly sourced from national official statistics websites.
According to Part I.A, Chapter B.I Annex III of Regulation (EC) 999/20013, the information to be
presented by the MS in their annual report should include animals other than bovine, ovine and
caprine, and the number of samples and confirmed TSE cases per species. Surveillance data in Europe
in 2015 have been extracted from the above-mentioned annual reports submitted by the MS and from
the background information provided by the European Commission and included in the mandate.
2.2. Methodologies
A literature search was performed in the framework of this mandate to inform the review of the
evidence in the scientific literature on the topics covered by the three ToRs. The literature search was
used to support the expert review of these areas, and additional scientific information known by the
experts was also considered in the assessment.
The search string used for the literature search was: (‘chronic wasting disease’ OR CWD OR
wasting OR TSE* OR BSE OR scrapie OR PrP* OR PRNP OR prion*) AND (surveillance OR prevalence
OR incidence OR epidem* OR introduc* OR spread OR risk OR ‘public health’ OR zoono*) AND (deer*
OR cervid* OR moose* OR elk* OR reindeer*). These terms were searched in the titles and abstracts
of the scientific publications. The search was conducted in the PubMed/MEDLINE database. The search
was restricted to the following languages: English, Estonian, Finnish, French, Icelandic, Latvian,
Norwegian, Polish and Swedish. The publication dates were unrestricted. A total of 238 references was
retrieved and screened for studies of interest, mainly with regard to the tissue distribution of CWD. A
subset of 26 references were considered potentially relevant and reviewed in full.
A literature search was performed in the framework of this mandate to inform the review of the
evidence in the scientific literature on the in vivo and in vitro experimental studies showing the
transmissibility of the TSE agents to humans. In particular, the search was aimed at identifying new
scientific evidence that has become available subsequent to the publication of the 2015 EFSA scientific
opinion ‘on a request for a review of a scientific publication concerning the zoonotic potential of ovine
3 Regulation (EC) No 999/2001 of the European Parliament and of the Council of 22 May 2001 laying down rules for the
prevention, control and eradication of certain transmissible spongiform encephalopathies. OJ L 147 31.5.2001, p. 1.
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scrapie prions’ (EFSA BIOHAZ Panel, 2015). The literature search was used to support the expert review of
these areas, and additional scientific information known by the experts was also considered in the review.
The search string used for the literature search of in vivo transmission studies of TSE in animal
models exploring the zoonotic potential of CWD was: (BSE OR TSE OR scrapie OR CWD OR *CJD OR
Nor98 OR Nor-98 OR spongiform encephalopa* OR ‘chronic wasting disease’ OR ‘creutzfeldt-jakob’
OR ‘creutzfeldt jakob’ OR prion OR prp*) AND (transmissible OR transmission OR transmitted OR
transgenic OR barrier OR passage* OR tg OR humanised OR humanized). These terms were searched
in the titles of the scientific publications. The search was conducted in the following databases: ISI
Web of Knowledge; CAB Abstracts; Current Contents; FSTA; Journal Citation Report and Web of
Science. The search was restricted to English language and from 1 January 2015 until 9 September
2016, since the opinion covered extensively the topic until 2015. A total of 101 references were
retrieved and screened for studies of interest. A subset of 10 references were considered potentially
relevant and reviewed.
The search string used for the literature search of in vitro transmission studies of TSE in animal models
exploring the zoonotic potential of CWD was: (BSE OR TSE OR scrapie OR CWD OR *CJD OR Nor98 OR
Nor-98 OR spongiform encephalopa* OR ‘chronic wasting disease’ OR ‘creutzfeldt-jakob’ OR ‘creutzfeldt
jakob’ OR prion OR prp*) AND (misfold* OR conversion OR ‘in vitro’ OR ‘in-vitro’ OR amplification OR
passage* OR cycl* OR substrate OR *quic OR ‘asa’ OR pmca OR quaking). These terms were searched in
the titles of the scientific publications. The search was conducted in the following databases: ISI Web of
Knowledge; CAB Abstracts; Current Contents; FSTA; Journal Citation Report and Web of Science. The
search was restricted to English language and from 1 January 2015 until 9 September 2016, since the
opinion covered extensively the topic until 2015. A total of 119 references was retrieved and screened
for studies of interest. A subset of 4 references was considered potentially relevant and reviewed in
detail.
It was agreed, due to limited time and resources, to carry out a qualitative evaluation, by means of
literature reviews based on the knowledge and expertise of the Working Group (WG) members. In
these cases, the experts in the WG selected relevant references starting from scientific papers
including review papers, books chapters, non-peer-review papers known by the experts themselves or
retrieved through non-systematic searches, until the information of the subject was considered
sufficient to undertake the assessment by the WG.
3. Assessment
3.1. Chronic wasting disease (CWD): background
3.1.1. Origin of the disease
The origins of CWD are not clear. How different TSE have spread and become established in
populations is reasonably well understood, but where the ‘index case’ came from has never been
identified. It is also unclear whether all of the known foci can be tied to a single event or whether
there have been multiple ‘origin’ events (Williams and Young, 1992; Williams and Miller, 2002, 2003). It
has been speculated for some other animal TSE, in particular the atypical forms of scrapie and bovine
spongiform encephalopathy (BSE), that disease may have a spontaneous origin, but this has not been
conclusively proved (Casalone et al., 2004; Fediaevsky et al., 2008, 2010; Baron et al., 2011; Ortiz-
Pelaez et al., 2016). The origins of classical forms of TSE have never been established, and although it
has been speculated that naturally occurring TSE may at some point have crossed between animal
species, there is again no unequivocal evidence to support or refute these hypotheses.
This lack of understanding of the origins of disease means that we do not know whether the recent
identification of disease in European cervids is necessarily linked to the pre-existing disease in
North America, or if it could be unrelated. The absence of any previous systematic monitoring or
surveillance of European deer might have allowed disease to exist undetected for a long time (EFSA
BIOHAZ Panel, 2010).
While the source of disease in many settings in North America almost certainly relates to the highly
contagious transmission of CWD prions from diseased animals and to inadvertent or natural
movements of infected animals, the ultimate origins of CWD remain a mystery in both Norway and
North America.
Possible explanations of the origin of CWD include the spontaneous conversion of normal cervid
prion protein (PrP) into abnormal form of PrP (PrPSc) that is transmissible to other wapiti and deer
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(Odocoileus spp.), or the transmission of prions causing diseases in other species to cervids. CWD could
also have originated by infection with an as-yet-unrecognised prion. Consistent with the first hypothesis,
high resolution structural studies showed the loop region linking the second beta-sheet (b2) with the
alpha2-helix (a2) of cervid PrP to be extremely well defined compared with most other species, raising
the possibility that this structural characteristic correlates with the ease with which contagious
transmission of CWD occurs (Gossert et al., 2005). Consistent with this, transgenic (Tg) mice expressing
mouse PrP, in which the b2–a2 loop was replaced by the corresponding region from cervid species,
spontaneously developed prion disease (Sigurdson et al., 2009). Additional studies consistently point to
the importance of the b2–a2 loop in regulating transmission barriers, including that of CWD to humans
(Kurt et al., 2009; Sigurdson et al., 2010; Kurt et al., 2014, 2015). However, subsequent work
suggested a more complex mechanism in which the b2–a2 loop participates with the distal region of
a-helix 3 to form a solvent-accessible contiguous epitope (Perez et al., 2010). These and other studies
(Christen et al., 2009) ascribed greater importance to the plasticity of this discontinuous epitope.
There has been long-standing speculation that CWD derived from the interspecies transmission of
scrapie, a disease that has been recognised in domestic sheep in the United States since 1947. Several
studies have been performed to address this possibility (Race et al., 2002), including experimental
intracerebral inoculation of deer and wapiti with scrapie prions (Hamir et al., 2003, 2004; Greenlee
et al., 2011). Of six wapiti inoculated with scrapie, three presented with neurological signs and
neuropathology, but only after long and variable times to disease onset, ranging from 25 to
46 months. The brains of these scrapie-infected wapiti were indistinguishable from CWD by
histopathological examination or IHC (Hamir et al., 2004). Two subsequent studies showed relatively
easy transmission of scrapie to white-tailed deer; in both cases all inoculated animals developed
disease within 19–20 months (Greenlee et al., 2011). Additional findings indicate other similarities
between CWD and scrapie in white-tailed deer. While there was no lymphoid spread of scrapie in
wapiti (Hamir et al., 2004), the early and widespread presence of PrPSc in lymphoid tissues of scrapie-
challenged deer (Greenlee et al., 2011) is similar to CWD (Sigurdson et al., 1999). Finally, western blot
showed that PrPSc in the obex region of scrapie-infected deer have a molecular profile consistent with
CWD, but distinct from tissues of the cerebrum or the scrapie inoculum (Greenlee et al., 2011).
While these data indicate that scrapie can transmit intracerebrally to deer, the number of scrapie
isolates and recipient animals is very small, and the outcome is a disease that presents some
differences from CWD, so no conclusions can be drawn with regard to any causal relationship.
3.1.2. History of CWD
CWD was first identified in the late 1960s as a fatal wasting syndrome of mule deer
(Odocoileus hemionus hemionus) in a northern Colorado research facility (Williams and Young, 1980,
1992). Although the disease was initially considered to be a nutritional deficiency and/or related to
stresses caused by captivity, CWD was ultimately recognised as a TSE in 1978 by histopathological
assessment (Williams and Young, 1980, 1982). Subsequent to its initial recognition in the northern
Colorado research facility, CWD was identified in mule deer in a research facility in Wyoming. Soon
thereafter CWD was diagnosed in captive wapiti in both the Colorado and Wyoming facilities.
In 1980, following this description of CWD as a TSE, a case was confirmed by neuropathological
assessment of a mule deer that had died at the Toronto Zoo in 1978, at which time the diagnosis was
‘spongiform encephalopathy’. This animal had clinical signs now known to be compatible with CWD. A
retrospective study of cervids resident at the Toronto Zoo between 1973 and 2003 revealed additional
CWD cases, the last case being in 1981 (Dube et al., 2006). Analyses included examination of
management, animal health and post-mortem records, and immunohistochemical studies. CWD was
ultimately diagnosed in eight out of 105 animals tested: seven mule deer and one black-tailed deer
(O. hemonius columbianus). The most likely method of introduction was the importation of CWD-
infected animals from a zoo in the United States. Animal-to-animal contact and environmental
contamination were the most likely methods of spread of CWD at the Toronto zoo. Although CWD was
not diagnosed in cervid species other than mule or black-tailed deer, the Toronto zoo either donated or
sold a total of 108 wapiti, 8 moose, 83 reindeer/caribou and 31 white-tailed deer to other zoos,
government agencies, or universities from 1976 to 2002 (Dube et al., 2006).
CWD is unique among prion diseases as being the only known prion disease of free-ranging, as well
as captive animals. Disease was found in free-ranging mule deer and wapiti in south-eastern Wyoming
and north-eastern Colorado soon after its recognition as a TSE (Williams and Young, 1992; Spraker
et al., 1997). Subsequent surveillance and modelling studies indicated that CWD occurred endemically
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among free-ranging deer and wapiti in a contiguous area in north-eastern Colorado, south-eastern
Wyoming and western Nebraska, and that CWD most likely had been present in free-ranging cervids in
this ‘endemic region’ for several decades prior to its eventual recognition (Miller et al., 2000). In recent
years, CWD has been detected in wild (Baeten et al., 2007) and captive moose (Alces alces shirasi)
(Kreeger et al., 2006) in the endemic region.
Although first thought to be limited in to the endemic region in the wild, additional foci of disease
in free-ranging animals, distant from the endemic region, have been identified. In 2000, CWD was
detected in Saskatchewan, Canada, and in 2002, a third free-ranging population with CWD was
identified in southern Wisconsin (Joly et al., 2003). Ultimately additional, apparently separate foci
were reported in New Mexico, New York, West Virginia, Missouri, Minnesota and Arkansas. While
identification of CWD-affected animals in areas previously thought to be free of infection may be partly
related to increased surveillance, spread of the disease by natural migration of infected animals, and
by the translocation of infected cervids by humans, have almost certainly played a role in the
emergence of disease in new locations. The latter mechanism is exemplified by CWD outbreaks
occurring in South Korea, which resulted from the importation of subclinically infected Canadian
animals (Sohn et al., 2002; Kim et al., 2005).
The occurrence of CWD in captive herds in new locations has, in some cases, preceded detection of
the disease in free-ranging animals. This raised the possibility that the origins of CWD in wild animals in
Saskatchewan, New York state and Missouri were spillovers of disease from captive facilities in or before
1996–2001, 2005 and 2010, respectively. Disease continues to be detected in new geographic locations
and with increasing prevalence in some areas where the disease has been monitored the longest (Miller
The historical occurrence at the Toronto Zoo (Ontario, Canada) is not shown on the map (https://www.nwhc.
usgs.gov/disease_information/chronic_wasting_disease)
Figure 1: Distribution of CWD in North America in as of October 2016. Source: USGS
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and Fischer, 2016). At the time of writing, CWD has been documented in captive and free-ranging deer
in 24 states of the USA and three Canadian provinces. Since the beginning of 2016, CWD has been
documented in free-ranging deer and wapiti populations in new geographic locations within several
endemic jurisdictions (Alberta, Nebraska, Texas, Missouri, Colorado and Wyoming), and was detected
for the first time in Arkansas. The disease was also detected in new facilities for captive white-tailed
deer in Texas and Wisconsin. A map of the current known distribution of CWD in North America,
available from the United States Geological Survey (USGS) National Wildlife Health Center (NWHC), is
shown in Figure 1. In addition, the detection of CWD in wild reindeer (Benestad et al., 2016) in April
2016 and subsequently moose in May 2016, announced by the Norwegian Veterinary Institute and the
Norwegian Environment Agency, represent the first documented cases of CWD in Europe.
CWD can have a variety of effects on jurisdictions where cervids represent an important economic,
ecologic or sociologic resource. CWD has both a significant economic impact and influences wildlife
conservation. The US Fish and Wildlife Service estimated that a total of $33.7 billion was spent on
hunting items in 2011, and an estimated 11.6 million hunters pursued big game such as deer and
wapiti (U.S. Department of the Interior, U.S. Fish and Wildlife Service, and U.S. Department of
Commerce, U.S. Census Bureau, 2011). The Wisconsin Department of National Resources spent
approximately $5 million annually on CWD management from 2002 until 2006 (Wisconsin Department
of Natural Resources, 2012). Saskatchewan spent ~$30 million to eradicate the disease within infected
commercially operated game farms (Oklahoma Department of Wildlife Conservation, 2002).
Beyond the direct effect on productivity of infected cervid herds or populations when prevalence
becomes high, infection at any level has variable impact on animal movements, management options,
and public perceptions about food safety. To date these impacts have not been catastrophic, but the
potential for greater impacts remains a possibility given experiences with other animal prion diseases.
3.1.3. Pathogenesis
Data indicate that the general pathogenesis of CWD is similar to that recorded for classical scrapie,
with detectable involvement of the lymphoreticular system (LRS) preceding that of the central nervous
system (CNS) (Sigurdson et al., 1999; Fox et al., 2006). As in sheep, host genotype has an effect on
how disease develops but, unlike the situation for scrapie, this seems to relate more to the length of
incubation period than to the pathogenesis or ultimate dissemination of the agent within tissues
(Fox et al., 2006; Johnson et al., 2011; Miller et al., 2012).
Like other prion diseases, lesions are confined to the CNS and consist of intraneuronal vacuolation,
neuropil spongiosis, astrocytic hypertrophy and hyperplasia (Williams and Young, 1993). Florid amyloid
plaques also feature in the neuropathology of diseased deer (Liberski et al., 2001). CWD is characterised
by extensive CNS and lymphoid tissue deposition of PrPSc, the latter being detectable at early stages of
the disease (Sigurdson et al., 1999; Fox et al., 2006); however, again, CWD pathogenesis seems to vary
between deer and wapiti with less PrPSc deposition in the lymphoid tissues of wapiti compared with deer
(Race et al., 2007). This early peripheral PrPSc accumulation can hypothetically be used to improve
surveillance sensitivity, but involvement of tissues readily accessible in the live animal, such as the
rectoanal mucosa-associated lymphoid tissue (RAMALT) are not consistently affected in earliest stages of
infection. Infectivity has been detected in saliva and in urine, supporting a role for these body fluids in
transmission and dissemination. Faecal material from subclinical deer also harbours infectivity (Haley
et al., 2009a; Tamg€uney et al., 2009). These excreta may also offer some potential for surveillance/
screening. The list of tissues affected by the time clinical disease develops includes edible tissues such as
the heart, liver, kidney, tongue, pancreas (Fox et al., 2006; Sigurdson et al., 2001), blood (Mathiason
et al., 2006) adipose tissue and LRS, and those used as dietary supplements (e.g. antler velvet).
Table 1 summarises the documented evidence for total detectable tissue distribution of PrPSc and/or
infectivity, as determined by a range of methods (IHC, WB, protein misfolding cyclic amplification
(PMCA), real-time quaking-induced conversion (RT-QuIC) or bioassay), regardless of the stage of
disease. A detailed analysis of the timescale and specific pathogenesis in individual species is beyond
the scope of this opinion.
Signs in clinically affected animals include weight loss, behavioural alterations, apparent ruminal atony
and salivary drooling in late stages of disease. Clinical features also include gradual loss of body condition,
resulting in emaciation, hence the term ‘wasting disease’, and behavioural changes that include
generalised depression, and loss of fear of humans (Williams, 2003). At later stages, affected animals may
display polydipsia and polyuria, sialorrhoea and generalised incoordination. The clinical course in captive
animals is slowly progressive, and after diagnosis most animals survive for a few weeks up to 3–4 months.
Chronic wasting disease (CWD) in cervids
































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































‘The PRNP gene is remarkably conserved within the family Cervidae; only 16 amino acid
polymorphisms have been reported within the 256 amino acid open reading frame in the third exon of
the PRNP gene. Some of these polymorphisms have been associated with lower rates of CWD infection
and slower progression of clinical CWD’. (Robinson et al., 2012)
As demonstrated in other species in which prion diseases occur naturally, susceptibility to CWD is
highly dependent on polymorphic variation in the deer and wapiti PRNP gene. In mule deer, the
polymorphism at codon 225 encoding serine (S) or phenylalanine (F) influences CWD susceptibility, the
225F allele being partially protective. The occurrence of CWD was found to be 30-fold higher in deer
homozygous for serine at position 225 (225SS) than in heterozygous (225SF) animals; the frequency
of 225SF and 225FF genotypes in CWD-negative deer was 9.3%, but only 0.3% in CWD-positive deer
(Jewell et al., 2005). Recent studies comparing CWD susceptibility in mule deer of the two residue 225
genotypes (225SS, 225FF) showed that 225FF mule deer had differences in clinical disease
presentation, as well as more subtle, atypical traits (Wolfe et al., 2014). Immediately adjacent to the
protective mule deer PrP polymorphism at 225, residue 226 encodes the singular primary structural
difference between wapiti/red deer and North American deer (Odocoileus spp.) PrP. Wapiti PrP
contains glutamate (E), and deer PrP glutamine (Q) at this position.
Polymorphisms at codons 95 glutamine (Q) or histidine (H) (Johnson et al., 2003), 96 glycine (G) or
serine (S) (Raymond et al., 2000; Johnson et al., 2003) and 116 alanine (A) or glycine (G) (Heaton
et al., 2003) in white-tailed deer have been reported. While all major genotypes were found in deer
with CWD, the Q96, G96, A116 allele (QGA) was more frequently found in CWD-affected deer than the
QSA allele (Johnson et al., 2003; O’Rourke et al., 2004). The wapiti PRNP coding sequence is also
polymorphic at codon 132 encoding either methionine (M) or leucine (L) (Schatzl et al., 1997;
O’Rourke et al., 1998). This position is equivalent to human PRNP codon 129. Studies of free-ranging
and captive wapiti with CWD (O’Rourke et al., 1999), as well as oral transmission experiments (Hamir
et al., 2006a; O’Rourke et al., 2007), indicate that the 132 L allele partially protects against CWD.
Transgenic (Tg) mouse modelling has provided a means of assessing the effect of cervid PrP gene
polymorphisms on CWD. Investigations combining studies in Tg mice, the natural host, cell-free prion
amplification and molecular modelling approaches analysed the effects of deer polymorphic amino acid
variations on CWD propagation and susceptibility to prions from different species (Angers et al., 2014).
The properties of CWD prions were consistently maintained in deer following their passage through Tg
mice expressing cognate PrP, reflecting the general authenticity of the Tg modelling approach. Moreover,
the protective influences of naturally occurring PrP polymorphisms on CWD susceptibility were accurately
reproduced in Tg mice, or during cell-free amplification. The resistance to CWD of Tg mice expressing
deer PrP S96, referred to as Tg(DeerPrP-S96)7511 mice, is consistent with previously generated Tg60
mice expressing serine at residue 96 (Meade-White et al., 2007). In the studies of Angers et al. (2014),
whereas substitutions at residues 95 and 96 affected CWD propagation, their protective effects were
negated during replication of sheep prions in Tg mice and, in the case of residue 96, deer.
To more fully address the influence of the wapiti 132 polymorphism, transmissibility of CWD prions
was assessed in Tg mice expressing cervid cellular PrP (PrPC) with L or M at residue 132 (Green et al.,
2008). While Tg mice expressing CerPrP-L132 afforded partial resistance to CWD, SSBP/1 sheep scrapie
prions transmitted efficiently to Tg mice expressing CerPrP-L132, suggesting that the wapiti 132
polymorphism controls prion susceptibility at the level of prion strain selection. The susceptibility of Tg
mice expressing deer PrP with S at residue 96, referred to as Tg(DeerPrP-S96)7511, albeit with
incomplete attack rates and long incubation times, is at odds with previous work showing complete
resistance of Tg60 mice (Meade-White et al., 2007; Race et al., 2011). This apparent discrepancy is
most likely related to the low transgene expression in Tg60 mice, reported to be 70% of the levels
found in deer. CWD occurs naturally in deer homozygous for the PrP-S96 allele (Keane et al., 2008a),
which is clearly inconsistent with a completely protective effect of this substitution, suggesting that Tg
(DeerPrP-S96)7511 mice represent an accurate Tg model in which to assess the effects of the S96
substitution.
Tg mice expressing wild-type deer PrP (Tg33) or Tg60 were challenged with CWD prions from
experimentally infected deer with varying polymorphisms at residues 95 and 96 (Duque Velasquez
et al., 2015). Passage of deer CWD prions into Tg33 mice expressing wild-type deer PrP resulted in
100% attack rates, with CWD prions from deer expressing H95 or S96 having significantly longer
incubation periods. Remarkably, otherwise resistant Tg60 mice (Meade-White et al., 2007; Race et al.,
2011) developed disease only when inoculated with prions from deer expressing H95/Q95 and H95/S96
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PrP genotypes. Serial passage in Tg60 mice resulted in propagation of a novel CWD strain, referred to as
H95(+), while transmission to Tg33 mice produced two disease phenotypes consistent with propagation
of two strains.
Recent findings show that residue 225, which is polymorphic in mule deer, and 226, which differs
between wapiti and deer, play a critical role in PrPC-to-PrPSc conversion and strain propagation, but that
their effects are distinct from those produced by the H95Q, G95S and M132L polymorphisms (Angers
et al., 2014). Structural analyses confirm that residues 225 and 226 are located in the distal region of
a-helix 3 that participates with the b2–a2 loop to form a solvent-accessible contiguous epitope (Perez
et al., 2010). Consistent with a role for this epitope in PrP conversion, these polymorphisms severely
impact replication of both the scrapie isolate SSBP/1 and, to variable degrees, CWD. In the case of Tg
mice expressing deerPrP-F225, referred to as Tg(DeerPrP-F225), SSBP/1 incubation times were
prolonged threefold, whereas inoculation with CWD produced incomplete attack rates or prolonged and
variable incubation times in small numbers of mice. In those Tg(DeerPrP-F225) mice that did succumb
to CWD, PrPSc distribution patterns were altered compared with Tg(DeerPrP) mice.
To address the effects of substitution of glutamic acid (E) for glutamine (Q) at residue 226, recent
studies assessed whether Tg mice expressing wild-type wapiti or deer PrP differed in their responses to
CWD. These studies showed that differences at residue 226 affected CWD replication, but to a lesser
degree than the residue 225 polymorphism, with disease onset prolonged by 20–46% in CWD-
inoculated Tg(Deer PrP) compared with Tg(ElkPrP) mice, and PrPSc distribution and neuropathology
varying in each case (Angers et al., 2009). In contrast to Tg(DeerPrP) mice which are susceptible to
SSBP/1 (Green et al., 2008), Tg(ElkPrP) were completely resistant (Angers et al., 2009), although the
resistance of wapiti PrPC to propagation of SSBP/1 was overcome following adaptation in deer or Tg
(DeerPrP) mice. Passage in Tg mice expressing E226 or Q226 profoundly affected the ability of SSBP/1
to reinfect Tg mice expressing sheep PrPC. These studies paralleled aspects of previously published
studies indicating that amino acid differences at residue 226 controlled the manifestation of CWD
quasispecies or closely related strains (Angers et al., 2010). These findings therefore collectively point
to an important role for residues 225 and 226 in PrPC-to-PrPSc conversion and the manifestation of
prion strain properties, and substantiate the view that long-range interactions between the b2–a2 loop
and a-helix 3 provide protection against prion infection and suggest a likely mechanism to account for
the protective effects of the F225 polymorphism. Molecular dynamics analyses (Angers et al., 2014)
showed that the S225F and E226Q substitutions in deer alter the orientations of D170 in the b2–a2
loop and Y228 in a-helix 3. This structural change allows hydrogen bonding between the side chains of
these residues, which results in reduced plasticity of the b2–a2 loop/a-helix 3 epitope compared with
deer or wapiti PrP structures. This suggests that the increased stability of this tertiary structural
epitope precludes PrPC-to-PrPSc conversion of deerPrP-F225. However, some clinical cases in animals
with this genotype have been reported (Wolfe et al., 2014).
The three Norwegian reindeer confirmed positive to CWD (up to 21 November 2016) had the same
PrP genotype as the two successfully orally inoculated reindeer in the Canadian study (Mitchell et al.,
2012), GG129 SS138 VV169. Nevertheless other PrP genotypes also seem to be susceptible following
either IC inoculation or contact, if not even more susceptible to CWD (Moore et al., 2016). Table 2
shows a summary of the polymorphisms identified in the PRNP gene of cervid species in North America
(adapted from Robinson et al., 2012).
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59S 0.2% S E
98A 8% A E
168S 0.2% S E
226Q 44%
Sika deer Jeong et al. (2007)
100S/226E E Meng et al. (2005)
100G 3% G E
226Q 48%
Fallow deer Rhyan et al. (2011)
Monomorphic 100% N E
Subfamily Capreolinae





95H 2% H Kelly et al. (2008)
96S 26% S O’Rourke et al. (2004)
116G 13% S Wilson et al. (2009)
226K 0.5% K Heaton et al. (2003)
138N pseudogene 15% N Brayton et al. (2004)
Mule deer Jewell et al. (2005)
20D/138S/225S Jewell et al. (2005)
20G 9% G Wilson et al. (2009)
225F 5% F Heaton et al. (2003)
138N pseudo gene ~ 100% N
Moose Huson and Happ (2006)
209M
209I 45% I





2M/129S/169M 4% M S M




Jeong et al. (2009)
100S
100N na N
Amino acid codes: A: alanine; D: aspartic acid; E: glutamic acid; F: phenylalanine; G: glycine; H: histidine; I: isoleucine; K: lysine; L: leucine; M: methionine;
N: asparagine; P: proline; Q: glutamine; R: arginine; S: serine; T: threonine; V: valine.
(a): Adapted from Robinson et al. (2012).
(b): When blank, data on other polymorphisms not reported by the publication.
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3.1.5. Mechanisms of natural transmission
Chronic wasting disease is infectious (Williams and Young, 1980, 1992; Miller and Williams, 2003),
and infected individuals shed prions naturally via multiple routes. CWD has been detected in saliva and
blood by bioassay (Mathiason et al., 2006), and urine by PMCA (Haley et al., 2009a) and bioassay
(Haley et al., 2009b), suggesting a role for these body fluids in transmission and dissemination. Faecal
material from subclinical deer also harbours infectivity (Haley et al., 2009b; Tamg€uney et al., 2009),
which is consistent with the mechanism of contagious lateral transmission. The detection of CWD
prions in wapiti antler velvet by transgenic bioassay, and the annual shedding of this material, raises
the possibility that it may also play a role in CWD transmission (Angers et al., 2009). Nasal secretions,
milk and semen seem likely to be additional sources of agent shedding (Gough and Maddison, 2010).
Prion shedding occurs intermittently throughout much of the disease course (Tamg€uney et al., 2009).
Oral exposure appears to be the predominant route of natural infection (reviewed by Williams and
Miller, 2002; Williams, 2005; Saunders et al., 2012), although maternal transmission has also been
shown to occur experimentally in Reeves’ muntjac deer (Muntiacus reevesi) (Nalls et al., 2013), and
possibly contributes to the efficient transmission of CWD in naturally exposed cervid populations
(Chapuis et al., 2016). The highly efficient transmission of CWD appears unparalleled among prion
diseases (Williams and Young, 1980; Miller et al., 2000; Miller and Williams, 2003).
Susceptible hosts may be exposed either directly through interaction with an infectious host or
indirectly through prion-contaminated food, water, or environments (Miller and Williams, 2003; Miller
et al., 2004; Mathiason et al., 2009). Its’ remarkably contagious nature has been documented in a
captive mule deer population wherein 90% of the mule deer present for more than 2 years ultimately
developed disease (Williams and Young, 1980). Ingestion of forage or water contaminated by
secretions, excretions, or other sources, for example, CWD-infected carcasses (Miller et al., 2004), has
long been thought the most plausible natural route. In addition to prions shed by an infectious host,
central nervous and lymphoid tissues (Sigurdson et al., 1999; Wolfe et al., 2012; also see Table 1) as
well as many others (reviewed by Williams, 2005; Haley and Hoover, 2015) carry infectivity that may
also represent sources of transmission if consumed by susceptible animals.
However, unlike BSE and transmissible mink encephalopathy (TME) in mink, none of the CWD
outbreaks investigated thus far has incriminated prion-contaminated feed as the driving force behind
transmission. Pertinent to this issue is the well-known persistence of prions in the environment, a feature
that is linked to their unusual resistance to degradation. The CWD prions in excreta and carcass remains
can persist for years in the environment (Williams and Young, 1992; Miller and Williams, 2003; Miller
et al., 2004). Coupled with this, prions bound to soil particles remain infectious after oral consumption
(Saunders et al., 2012; Johnson et al., 2007). Moreover, prion binding to soil elements (e.g. clay)
enhances persistence and infectivity (Johnson et al., 2007). Indirect transmission greatly complicates
CWD control strategies (Williams and Young, 1992; Williams et al., 2002; Miller et al., 2004).
3.1.6. Epidemiology
The occurrence of CWD in deer populations or in particular species may be very different but
caution is needed when considering field data. As reported by Williams (2005) in captive herds where
introduction of disease is thought to be recent, prevalence may be low (1%) but may approach 100%
in CWD endemic research facilities; in free-ranging populations, it may range between 1% and 30%
but is more frequently under 5% (Saunders et al., 2012). Mule deer seem to experience the highest
prevalence rates than other species (Spraker et al., 1997; Saunders et al., 2012). However, although
North American deer (Odocoileus spp.) generally show higher prevalence than wapiti or moose,
extraordinarily high rates have been described in captive wapiti so this may be more a function of
social and foraging behaviour differences.
There is no clear information on temporal trends. In general, until the mid-1990s only two or three
US states had reported cases; then over the subsequent 15 years an apparently rapid spread of the
disease has been observed in the country (Saunders et al., 2012), although it has been argued that
this reflects the efforts to detect disease (increased surveillance), and is not a ‘real time’ representation
of disease spread (Miller and Fischer, 2016).
Based on experimental oral infections, the incubation period for the onset of clinical signs in mule
deer has been estimated about 15 months and in wapiti between 12 and 34 months with most of the
clinical cases observed in animals between 2 and 7 years of age (Williams et al., 2002). In general,
male deer experience higher risk than females: e.g. in a cohort of mule deer (Miller et al., 2008) the
prevalence among the sampled adult male deer was about twice the prevalence among adult females.
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That is likely to be explained by different behaviour: males interact with more groups or roam more
widely while seeking to establish social dominance, increasing the contact rate with other animals in
general and with infected animals in particular, by their associating with numerous females, or by
fighting with other males (Koutnik, 1981).
For both sexes, the risk of infection appears to increase in early adulthood, resulting in relatively
high prevalence in adult (> 2-year-old) mule deer as compared with yearlings, and in a decline in older
age classes (Miller and Conner, 2005).
3.1.7. Risk factors
Many risk factors have been suggested to facilitate the introduction and spread of the disease
(Williams and Miller, 2003). They play a role in enhancing the ability of CWD prions to transmit both
directly (animal-to-animal) and indirectly via the contaminated environment.
The incursion of the disease into unaffected populations may be due to the natural migration of
cervids and/or the translocation of infected animals or soil by humans (Sohn et al., 2002; Department
for Environment Food & Rural Affairs (Defra, 2016)). Once introduced, the spread of the agent is
associated with the rate of contacts between animals. Behavioural and social factors have already
been mentioned to explain the higher risk for males than for females.
It has been shown that rates of between-group contacts increase with deer density (Habib et al.,
2011). For instance, the risk of spread in young (< 2-year-old) white-tailed deer in south-central
Wisconsin was non-linearly but positively associated with both frequency of disease (prevalence) and
density of infected deer (Storm et al., 2013). Increasing densities of the cervid populations by human
intervention, such as concentrating deer in captivity or by baiting or feeding them artificially, e.g. over
the winter season, (Miller and Williams, 2003; Sorensen et al., 2014) or by providing lick blocks, may
facilitate transmission. The local environmental characteristics (e.g. deer habitat) may increase the
probability of aggregation of animals and therefore of disease transmission (Miller and Conner, 2005).
In a study by Storm et al. (2013), landscape factors (e.g. deciduous forest cover and forest edge
density) were positively associated with infection rates. Areas where deer congregate seasonally may
be particularly important, as well as their tendency to concentrate and to become sedentary on their
winter range.
It has been observed that the prevalence of CWD at any particular point is correlated with distance
from the introduction point, as a surrogate for the time required for disease spread or ‘disease history’
(Joly et al., 2006).
As highlighted by the Norwegian Scientific Committee for Food Safety (Vitenskapskomiteen for
Mattrygghet (VKM), 2016 and Defra, 2016), CWD prions might enter the environment via carcass
decomposition, antler velvet and skin, saliva, urine, faeces, blood, and most probably via placenta and
milk. Exposure to environmental fomites (e.g. bedding and water) is sufficient to transmit CWD (Miller
et al., 2004; Mathiason et al., 2009). It has been suggested that people (in particular deer hunters,
given their increased contact with deer and their environment) travelling from a CWD-affected area
with potentially contaminated clothing/boots and/or equipment may act as long distance vectors of
disease (Defra, 2016).
A potential role in the transmission of disease has been suggested for cervid urine, collected and
distributed widely for use by hunters as an attractant/lure (Defra, 2016): the captive populations from
which the urine is collected may include preclinical cases of infection. This hypothesis drove a number
of US states to ban the use of natural deer urine for lures. Additional feed for reindeer, such as lichens,
can be harvested and traded and could be a potential source of infection. Other types of feed,
including pet food containing cervid protein, have also been hypothesised as a potential source of
incursion in CWD-free areas (Defra, 2012).
Finally, as mentioned earlier, genetics must be considered among the risk factors. Polymorphisms in
the PRNP gene appear to influence susceptibility (see section 3.1.4), even though this remains less
understood for CWD than the well-documented and strong genetic influence of the sheep PRNP on
scrapie.
3.2. Considerations on the host range of CWD and risk to human health
3.2.1. The species barrier
In addition to its increased geographic distribution, the known host range of CWD is also
expanding. Naturally infected species include while-tailed deer, mule deer, black-tailed deer, reindeer,
Chronic wasting disease (CWD) in cervids
www.efsa.europa.eu/efsajournal 20 EFSA Journal 2017;15(1):4667
moose and wapiti. Other cervid species are susceptible to CWD following experimental challenge.
These include European red deer (Martin et al., 2009) and muntjac deer (Nalls et al., 2013). Brain
material from CWD-infected white-tailed deer and wapiti produced disease in only four of 13
intracerebrally inoculated fallow deer (Hamir et al., 2008), and the same species remained free of
disease when cohoused in paddocks with CWD-affected mule deer (Rhyan et al., 2011), suggesting
relative resistance of this cervid species to CWD.
Experimental transmissions to species outside the cervid family either intracerebrally or orally, have
given mixed results. Studies have demonstrated that the CWD agent transmitted poorly to Syrian
golden hamsters, ferrets and mink (Bartz et al., 1998; Marsh et al., 2005; Sigurdson, 2008).
Experimentally susceptible species include several species of voles, white-footed mice, deer mice, cats,
raccoons and squirrel monkeys (Hamir et al., 2003, 2007; Race et al., 2009a; Heisey et al., 2010; Di
Bari et al., 2013; Mathiason et al., 2013; Race et al., 2014; Seelig et al., 2015). While non-transgenic
mice have been reported to be resistant to CWD infection (Browning et al., 2004), limited infection of
the VM/Dk inbred strain of mice by wapiti CWD has been reported (Lee et al., 2013). Bank voles
(Myodes glareoulos) are particularly susceptible to CWD (Di Bari et al., 2013).
Inoculation of prions into individuals of the same species will typically cause disease with remarkably
reproducible clinical signs. Whether the natural host range of CWD extends beyond the family Cervidae
is currently unclear. Barriers to transmission between species are characterised by protracted incubation
times compared with the permissive host, and/or low rates of infection with variable intervals to disease.
Further passage of the resulting pathogenic prions to animals expressing PrP of the new species results
in shorter, synchronous times to disease in all inoculated recipients, reflecting the adaptation of prions to
ensure continued propagation in the new host (reviewed in Baskakov, 2014).
The recognised importance of PrP primary structure in controlling prion adaptation across species
barriers paved the way for development of Tg mouse models that recapitulate natural prion diseases
(Telling, 2011), and model the susceptibility of at risk, or seemingly resistant species (Vidal et al., 2015;
Espinosa et al., 2009). While species-related primary structural incompatibilities between PrPSc and PrPC
expressed in the new host have a major impact on prion transmission barriers (Prusiner et al., 1990),
strain properties of the infectious agent have significant additional influence on the outcome of
interspecies prion transmissions, as exemplified by the extensive host range properties of BSE. In the
absence of an informational nucleic acid component in prions, heritable properties, including incubation
times and neuropathological profiles, are enciphered within the conformation of PrPSc, which varies
among different strains (Bessen and Marsh, 1994; Telling et al., 1996). The emergence of newly adapted
strains, which generally occurs as prions transit species barriers, is accompanied by changes in the
conformation of PrPSc constituting prions from the original host, compared to the PrPSc of prions produced
in the species of adaptation (Peretz et al., 2002). To reconcile the influences of conformationally
enciphered strain properties and species-dependent variations in PrP primary structure on adaptive
transmission, the conformational selection model postulated that PrP expressed in a newly infected host
selects a species-optimised prion from an ensemble of quasispecies conformations produced during
replication in the host of origin (Collinge and Clarke, 2007).
Tg mice are also used to model interspecies transmissions (Vickery et al., 2014), which are
generally inefficient, and usually characterised by low attack rates and/or long and variable incubation
times on primary transmission. Such Tg mouse models cannot always be considered as an accurate
proxy for the natural host, so a failure to transmit needs to be interpreted with caution (for review, see
EFSA BIOHAZ Panel, 2015). The initial barrier to propagation is thought to result from primary
structural incompatibilities between donor PrPSc and recipient PrPC resulting in inefficient PrPC
conversion. Ultimately, nascent PrPSc readily converts PrPC, and efficient prion propagation ensues in
the recipient species. The relative ease of transmission on serial passage reflects adaptation in the new
species (Telling, 2011).
Recent studies cast light on the importance of specific secondary structural elements during
adaptive trans-species transmissions, in particular the loop connecting the b2 and a2 regions
(Sigurdson et al., 2010; Kurt et al., 2015).
The remarkably high rate of CWD prion transmission brings into question the risk posed to livestock
from developing a novel CWD-related prion disease via shared grazing of CWD-contaminated
rangeland. This issue has been investigated by transmitting CWD via intracerebral inoculation to cattle
(Hamir et al., 2001, 2005, 2006b, 2007) and to sheep (Hamir et al., 2006b). In the case of cattle,
PrPSc was detected in approximately 40% of intracerebrally inoculated animals. Low rates of disease
also occurred in intracerebrally inoculated sheep and host genotype appeared to affect transmission
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efficiency. Tg mice expressing bovine PrP have also been challenged with CWD, thus far with negative
outcomes (Tamguney et al., 2006). However, Tg mice expressing ovine PrP challenged with CWD have
resulted in highly efficient, life-long asymptomatic replication of these prions in the spleen tissue, with
brain involvement at late stage (Beringue et al., 2012). Davenport and co-workers employed the RT-
QuIC assay to compare the conversion properties of CWD and BSE, as well as feline-adapted versions
of these prions (Davenport et al., 2015). CWD, BSE and feline-adapted CWD most effectively seeded
cervid, bovine and feline bacterially expressed recombinant PrP (rPrP), respectively, while feline
spongiform encephalopathy (FSE) prions converted more efficiently bovine than feline rPrP. To model
the potential of these prions to convert human PrPC, human rPrP was used as a substrate in RT-QuIC.
Remarkably, CWD, feline-adapted CWD, BSE and FSE all converted human rPrP, although not as
efficiently as sporadic CJD prions. These findings are similar to those in low-level, cell-free conversions
of human prion protein by BSE, CWD and scrapie prions (Raymond et al., 2000). Overall, these data
indicate that CWD can (or at least has the molecular potential to) infect other species following
experimental challenge, but with varying degrees of ease. These data cannot be directly extrapolated
to the likelihood of such infection occurring naturally.
3.2.2. Agent strains
Field observations of natural disease and epidemiology indicate, anecdotally, that there are at least
two, and possibly three distinct strains of CWD in North America. Early pathology data from the
Norwegian cases suggests that (in moose at least) a strain distinct from any seen in North America
may be involved (Section 3.3.2).
Although seminal studies in Tg mice (Browning et al., 2004), and subsequent work (LaFauci et al.,
2006) raised the possibility of CWD strain variation, the limited number of isolates and the lack of
detailed strain analyses in those studies meant that this hypothesis remained speculative. Subsequent
studies supported the feasibility of using Tg(CerPrP)1536+/ mice for characterising naturally occurring
CWD strains, and novel cervid prions generated by PMCA (Green et al., 2008). To address whether
different CWD strains occur in various geographic locations or in different cervid species, bioassays in
Tg mice were used to analyse CWD in a large collection of captive and wild mule deer, white-tailed
deer and wapiti from various geographic locations in North America (Angers et al., 2010). These
findings provided substantial evidence for two prevalent CWD prion strains, referred to as CWD1 and
CWD2, with different clinical and neuropathological properties. Remarkably, primary transmissions of
CWD prions from wapiti produced either CWD1 or CWD2 profiles, while transmission of deer inocula
favoured the production of mixed intrastudy incubation times of CWD1 and CWD2 neuropathologies.
These findings indicate that wapiti may be infected with either CWD1 or CWD2, whereas deer brains
tend to harbour CWD1/CWD2 strain mixtures.
The different primary structures of deer and wapiti PrP at residue 226 provide a framework for
understanding these differences in strain profiles of deer and wapiti. Because of the role played by
residue 226, the description of a lysine polymorphism at this position in deer, and its possible effect on
strain stability may be significant (Angers et al., 2010). It is unknown whether CWD1 and CWD2
interfere or act synergistically, or whether their coexistence contributes to the unparalleled efficiency of
CWD transmission. Interestingly, transmission results reported in previous studies suggested that
cervid brain inocula might be composed of strain mixtures (Tamg€uney et al., 2006).
Additional studies support the existence of multiple CWD strains. CWD has also been transmitted,
albeit with varying efficiency, to Tg mice expressing mouse PrP (Sigurdson et al., 2006; Tamg€uney
et al., 2006). In the former study, a single mule deer isolate produced disease in all inoculated Tga20
mice, which express mouse PrP at high levels. On successive passages, incubation times dropped. In
the second study, one wapiti isolate from a total of eight deer and wapiti CWD isolates induced disease
in 75% of inoculated Tg4053 mice, which also overexpress mouse PrP. The distribution of lesions in
both studies appeared to resemble the CWD1 pattern. Low efficiency CWD prion transmission was also
recorded in hamsters and Tg mice expressing Syrian hamster PrP (Raymond et al., 2007). In that
study, during serial passage of mule deer CWD, fast and slow incubation time strains with different
patterns of brain pathology and PrPSc deposition were also isolated. In yet other studies, serial
passages of CWD from white-tailed deer into Tg mice expressing hamster PrP, and then Syrian golden
hamsters, produced a strain, referred to as ‘wasting’ (WST), characterised by a prominent preclinical
wasting disease, similar to cachexia, which the authors proposed is due to a prion-induced
endocrinopathy (Bessen et al., 2011). These same investigators identified a second strain, defined as
‘cheeky’ (CKY), derived from infection of Tg mice that express hamster PrP (Crowell et al., 2015). The
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CKY strain had a shorter incubation period than WST, but after transmission to hamsters, the
incubation period of CKY became around  150 days longer than WST. In this case, proteinase K (PK)
digestion revealed strain-specific PrPSc signatures that were maintained in both hosts, but the solubility
and conformational stability of PrPSc differed for the CWD strains in a host-dependent manner. In
addition to supporting the view that there are multiple CWD strains, these findings suggest the
importance of host-specific pathways, independent of PrP, that participate in the selection and
propagation of distinct strains.
In one study, infection of hamsters with CWD from white-tailed deer, mule deer or wild white-tailed
deer resulted in phenotypic differences between isolates that were interpreted as indicative of different
strains (Triscott et al., 2015).
3.2.3. Approaches for the study of the zoonotic potential of CWD
There are many factors which influence the ability of any TSE agent to infect an animal (including
man), but the precise roles and potential for interdependence of these factors are not clear. It is
impossible to define an experimental model that encompasses all this potential variability and that directly
measures the likely transmission across a species barrier. Trying to assess the human species barrier is
even more difficult. There are therefore two main approaches to assessing zoonotic potential: looking at
the permeability of the species barrier and examining the link between animal and human TSE cases.
The effectiveness of the species barrier is determined not only by the host PRNP gene but also by the
infecting strain of the agent. This is potentially confounded by the observation that isolates may change
some or all of their phenotypic characteristics following either intra- or interspecies transmission.
For a comprehensive overview on the background, developments and principles of the factors
influencing the species barrier and the experimental approaches available as a proxy for assessing
zoonotic potential, see EFSA’s Scientific Opinion ‘on a request for a review of a scientific publication
concerning the zoonotic potential of ovine scrapie prions’ (EFSA BIOHAZ Panel, 2015).
3.2.3.1. Modelling the permeability of the transmission barrier
As noted above, experimental transmission of CWD to other species has yielded mixed results. The
resistance of mice (Browning et al., 2004) and the inefficient transmission to ferrets (Bartz et al.,
1998) are examples of species barriers to CWD prions, albeit of varying extent.
Seminal studies in Tg mice with sheep scrapie prions experimentally adapted to mice or Syrian
hamsters showed that optimal disease progression requires related PrPSc and PrPC primary structures
(Prusiner et al., 1990; Scott et al., 1993), which paved the way for the development of Tg models in
which to study human prions (Telling et al., 1995), and subsequently other naturally occurring
mammalian prions (reviewed in Telling, 2011). Tg approaches also suggested that PrPSc tertiary
structure enciphers strain information (Bessen and Marsh, 1994; Telling et al., 1996). Tg mice have
also been used to model interspecies transmissions (Vickery et al., 2014; EFSA BIOHAZ Panel, 2015).
Several Tg mouse models expressing either wapiti or deer PrP have been produced in which the
species barrier to CWD has been eliminated. Prototype Tg mice expressing deer PrP, designated Tg
(CerPrP)1536+/ (Browning et al., 2004), recapitulated the cardinal neuropathological, clinical and
biochemical features of CWD, an observation subsequently confirmed in comparable transgenic mouse
models expressing deer or wapiti PrP (Kong et al., 2005; LaFauci et al., 2006; Tamg€uney et al., 2006;
Meade-White et al., 2007; Angers et al., 2009). The generation of CWD-susceptible Tg mice, in concert
with the development of PMCA-based approaches for amplifying CWD infectivity using PrPC expressed
in the CNS of those mice (Green et al., 2008; Meyerett et al., 2008), has also provided crucial
information about the biology of CWD and cervid prions. Amplification in vitro was shown to maintain
CWD prion strain properties, and provided a means of generating novel cervid prion strains (Kurt
et al., 2007; Green et al., 2008; Meyerett et al., 2008; Kurt et al., 2009).
Tg mice and in vitro amplification approaches (reviewed in EFSA BIOHAZ Panel, 2015) have also
facilitated our understanding of the mechanism of CWD transmission among deer and wapiti
(Mathiason et al., 2006; Haley et al., 2009a,b; Tamg€uney et al., 2009). Transmission studies in Tg
(CerPrP)1536+/ and similar Tg mice demonstrated that CWD prions were present in urine and faeces
and saliva (Tamg€uney et al., 2006; Haley et al., 2009a), and these findings are substantiated by
in vitro amplification techniques (Haley et al., 2009b; Pulford et al., 2012; Henderson et al., 2013).
Tg approaches have been essential for assessing the potential risk of human exposure to CWD
prions (Angers et al., 2006, 2009; Race et al., 2009a). The identification and characterisation of
distinct CWD strains, and the influence of PrP primary structure on their stabilities, is of importance
Chronic wasting disease (CWD) in cervids
www.efsa.europa.eu/efsajournal 23 EFSA Journal 2017;15(1):4667
when considering the potential for interspecies transmission. The appearance of variant Creutzfeldt–
Jakob (vCJD) disease following human exposure to BSE (Bruce et al., 1997; Hill et al., 1997), placed
the human species barrier to other animal prion diseases, particularly CWD, at the forefront of public
health concerns during a period of time.
3.2.3.2. Establishing the link between human and animal TSE cases
North American hunters harvest thousands of deer and wapiti each year, and it is not mandatory to
have these animals tested, although the Centers for Disease Control and Prevention (CDC) publishes
guidance4 on the handling and dressing of carcases, and disposal of waste, designed to minimise
exposure to the highest risk tissues. However, the demonstration of CWD prions in the skeletal muscle
and fat of deer (Angers et al., 2006; Race et al., 2009b), means that humans may consume CWD
prions in enzootic areas. The substantial market for wapiti antler velvet in traditional Asian medicine
also warrants concern (Angers et al., 2009).
Estimates of the zoonotic potential of CWD are currently mixed. While initial cell-free conversion
studies suggested that the ability of CWD prions to transform human PrPC into PK-resistant PrP was
low (Raymond et al., 2000), subsequent results showed that cervid PrPSc induced the conversion of
human PrPC by PMCA, following CWD prion strain stabilisation by successive passages in vitro or
in vivo (Barria et al., 2011). These results have implications for the human species barrier to CWD, and
underscore the role of strain adaptation on interspecies transmission barriers. Wapiti CWD converted
human PrPC from the human brain, humanised mouse brain and human-derived PrPC overexpressing
cell lines in a PRNP-dependent manner, with higher efficiency for 129M. Most interestingly, the
resulting PrPSc resembled that of sporadic CJD (sCJD) of the MM1 subtype providing evidence that a
switch of the phenotype had occurred (Barria et al., 2014).
Additional studies using Tg mice expressing human PrPC showed that CWD failed to induce disease
following intracerebral inoculation (Kong et al., 2005; Tamg€uney et al., 2006; Sandberg et al., 2010).
CWD transmission was reported to non-human primates through intracerebral (80% attack rate) and
oral inoculation (15% attack rate) of squirrel monkeys (Saimiri sciureus) (Marsh et al., 2005; Race
et al., 2009a). Subpassage experiments demonstrated a reduction in the incubation period indicating
an initial species barrier. However, squirrel monkeys are evolutionarily quite far from humans.
Macaques are closer to humans, and are susceptible to BSE and L-type atypical BSE (L-BSE), and
classical scrapie. Current data suggests that macaques are more resistant to CWD, but challenges are
ongoing. Challenge with scrapie in the macaque model resulted in disease after 10 years (four times
longer than BSE) (Comoy et al., 2015), so it is still too early to draw conclusions based on the current
data regarding CWD (Mussil et al., 2015), as these animals have a lifespan of up to 30 years.
Moreover, using RT-QuIC to model the transmission barrier of CWD to human rPrP suggest that, at
the level of protein–protein interactions, CWD adapts to new species more readily than does BSE, and
that the barrier preventing transmission of CWD to humans may be less robust than estimated
(Davenport et al., 2015).
Epidemiosurveillance of human populations currently shows no evidence of transmission (Belay
et al., 2004; Mawhinney et al., 2006), but there is still no confirmed aetiology for sporadic CJD cases
that occur worldwide. Comparison of the CJD prevalence rates in North America relative to other
countries does not suggest a CWD-related problem in man. For example, the mean annual mortality
rates from CJD are relatively consistent at 1–1.5 cases per million in both Europe and North America.5
Longitudinal studies following known dietary exposure to CWD have not identified any causal links
with human disease (Mawhinney et al., 2006; Anderson et al., 2007), but given the very long
incubation periods for TSE in man, and the lack of robust global surveillance data for either the human
or animal populations over the appropriate time periods, it is not possible to rule out conclusively the
hypothetical possibility of transmission.
One means of assessing the potential causal links between animal and human TSEs that has been
used previously (EFSA BIOHAZ Panel (2011, 2015)) is to apply the Bradford Hill guidelines (Hill, 1965),
which continue to be used in public health to assess the strength of causal relationships in
epidemiology. The guidelines include consideration of the following criteria: strength, consistency,
specificity, temporality, biological gradient, biological plausibility, coherence, experiment and analogy.
Not all criteria in the guidelines need to be fulfilled to suggest a causal link and some of the criteria are
now judged to be less important than others, notably analogy and consistency. For disease with a long
4 See: http://www.cdc.gov/prions/cwd/prevention.html
5 See: http://www.cdc.gov/prions/cjd/occurance-transmisison.html
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latency, temporality is of greater importance. Table 3, first presented in 2011 and updated for classical
scrapie (EFSA BIOHAZ Panel, 2015), has been reviewed based on evidence currently available and the
assessment of the zoonotic potential of CWD by these criteria remains unchanged.
3.3. Surveillance and control of CWD: current situation
3.3.1. Surveillance
North American experiences with CWD surveillance and control have been reviewed recently (Miller
and Fischer, 2016; Uehlinger et al., 2016). Surveillance activities have been applied extensively to
CWD. Detection of cases, prevalence estimation, geographical spread and monitoring over time are the
main aims pursued and require the investigation of representative (i.e. valid) samples from the
populations of interest so that data can be interpreted.
However, farmed cervids may be considered as a particular type of livestock for which classical
surveillance designs are applicable, wildlife populations deserve a dedicated study design. Probability
sampling (i.e. a procedure like simple, systematic, or stratified random sampling that assures that each
unit in the population has equal probability of being selected), applied to obtain a representative set of
animals is not straightforward for these target populations, as sampling frames are not available. To
overcome this caveat, proxy (i.e. the random sampling of mutually exclusive areas containing animals)
is commonly used (Salman, 2008; Morrison et al., 2008). This strategy also ensures that the
geographical coverage is as comprehensive as possible, acknowledging the difficulties of achieving it.
This was a shortcoming identified in the evaluation of the previous surveillance exercise (EFSA BIOHAZ
Panel, 2010). As highlighted by Miller and Fischer (2016), one of the most common flaws in CWD
control efforts to date has been an initial underestimation of the affected area (often based on
inadequate surveillance and erroneous assumptions about how long disease has been present).
Alternative sampling strategies include, for instance, the application of two-stage cluster probability
sampling where, after the random selection of the land areas, individual deer are examined within
each sampled land area. As an alternative, convenience sampling based on road-killed or apparently
healthy hunter-shot animals can be applied. However, these samples may be biased since in the
former they may over-represent diseased animals (Krumm et al., 2005), and in the latter they may
over-represent either non-affected animals (avoidance) or diseased (vulnerable) animals (Conner et al.,
2000). An apparently sick animal could be easier to hunt, but hunters may refuse to shoot them
because they would count as part of their hunting quota and may not be suitable for human
consumption. Over-representation of diseased animals would be a helpful outcome that could be used
Table 3: Assessment of putative links between animal and human TSEs according to the criteria of

























6. Plausibility + + + + + + +
7. Coherence + +/
8. Experiment + + + +/ +
9. Analogy + + + + + + +
BSE: bovine spongiform encephalopathy; L-BSE: L-type atypical BSE; H-BSE: H-type atypical BSE; CWD: chronic wasting disease;
+: Some scientific evidence is available for a positive interpretation.
+/: Debatable or conflicting evidence is available.
(a): Classical BSE has not been identified in sheep, but two cases of BSE in goat have been reported in France and the UK.
(b): There are multiple strains of the Classical scrapie agent.
(c): A single study has reported transmission of a natural sheep classical scrapie isolate to primates (Comoy et al., 2015).
(d): When blank, no scientific evidence is available for a positive interpretation.
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to enhance disease detection, but it would be less appropriate if prevalence estimates in the general
population (i.e. at individual level) are required. However, estimating herd-level prevalence (i.e. the
prevalence of affected farms or of land areas containing population units) would be possible.
Nusser et al. (2008) suggested that a partial implementation of probability sampling mitigating
biases from convenience samples could be obtained by combining in two-stage cluster sample designs
the probability sampling of land areas and the convenience sampling of deer opportunistically shot in
each selected land area. Biases based on the apparent health of the animals, if so desired, may be
mitigated by training the hunters to avoid such biases by encouraging hunters to kill ‘sick’ animals for
control purposes.
Moreover, this design may also be more efficient by including an unequal probability sampling, i.e. a
probability-based oversampling of more informative first-stage sample areas (i.e. areas where deer are
deemed to show higher density). In this case, weighted estimates have to be used to account for
oversampling.
As mentioned above, for areas or countries where the disease has not been reported, the objective
of surveillance should be to detect cases, whereas where the disease has been confirmed, to set up a
continuous monitoring and the temporal and spatial characterisation of the disease should be the
priority. Thus, surveillance may be implemented for CWD detection in a country or (as is the case in
Norway) in areas other than those of original detection; then for initial and periodical estimation of
prevalence in the cervids of the affected areas.
Surveillance for CWD should be continuous in jurisdictions where foci have not been detected, whereas
monitoring may be episodic (e.g. at multiyear intervals) in other scenarios. Strategies for detecting ‘new’
foci vs those for following temporal trends have been reviewed in detail by Samuel et al. (2003).
However, random sampling (e.g. from harvested animals) seems better suited for providing
relatively unbiased prevalence or incidence estimates (Samuel et al., 2003), a risk-based strategy
focusing on subpopulations at expected higher risk may be particularly efficient when detection is the
primary aim. The detection of Norwegian CWD cases through screening of ‘suspect’ cervids illustrates
the potential effectiveness of this approach for detecting foci in other parts of Norway or in other
European countries. Experience in Colorado, Wyoming and Wisconsin has shown that the probability of
finding a CWD-positive animal may be greater among sick-looking animals than the general population,
and those involved in road accidents or killed by predators (Krumm et al., 2005, 2009; Miller et al.,
2008). As an example of the relative vulnerability of CWD-infected individuals to vehicle collisions,
CWD prevalence among vehicle-killed mule deer in northern Colorado was between 1.6 and 15.9 times
higher than the estimated CWD prevalence among mule deer of the same sex sampled in the vicinity
of collision sites.
In wildlife, passive surveillance based on the reporting of ‘indicator animals’ (sick or suspicious or
fallen stock) may be particularly helpful in detecting new cases of a disease (Thulke et al., 2009;
Guberti et al., 2014). However, when sampling collection depends on the voluntary reporting of sick or
dead wild animals it may be difficult to obtain a large number of samples for several reasons: (a) most
animals with clinical signs will not be observed/detected in the wild; (b) it may be difficult to gain access
to the carcass (deep in the forest, in rivers); (c) the need of transport from remote areas; (d) low
quality of the material (advanced autolysis so there is no brain left) (Bollinger et al., 2004). Moreover in
Europe, CWD is a new disease and, without awareness campaigns, little knowledge is expected among
stakeholders about the clinical signs and the species/subpopulations likely to be affected.
The addition of other sources of animals in surveillance may improve the ability to detect cases, for
example, with road-killed cervids or hunted sick animals. The results of the CWD surveillance
conducted in the EU between 2006 and 2010 showed that 81 wild red deer and white-tailed deer
tested were in the clinical/sick group (1.1%), 277 were fallen animals (3.8%) and 215 were road
injured/killed animals (2.9%) (EFSA BIOHAZ Panel, 2010). Therefore, the sampling of vehicle-killed
animals may be exploited to increase the efficiency of surveillance programmes designed to detect
new foci of CWD infection (Miller and Conner, 2005). Other subpopulations at expected higher risk are
those including any animal discarded at hunting (hunted but not used for consumption because of
anything abnormal, or poor body condition) or discarded at slaughter inspection (game slaughtering,
reindeer slaughtering).
Finally, effective surveillance should also account for the characteristics of the disease of interest,
i.e. it is necessary to apply an appropriate disease distribution model within the population. For
instance, a random disease distribution model would assume that cases are distributed without
depending on any specific factor such as neighbouring infected animals or environmental
contamination. This model is unrealistic if applied to CWD: Miller and Conner (2005) showed that a
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more realistic disease distribution model is given by the clustering of diseased animals within the cervid
population. Nusser et al. (2008) used the expression ‘hot spot and spark model’ suggesting a CWD
distribution with most of the diseased animals clustered and with a few additional outlying cases.
Surveillance should occur at biologically relevant spatial scales in view of the highly clustered
distribution of CWD in wild cervids. Prevalence in foci of disease is usually lower than 5% (Saunders
et al., 2012) requiring continuous monitoring over several years to detect disease. However,
prevalence may be as high as 30% (Saunders et al., 2012) and therefore the sample size needed to
detect the presence of disease may be relatively low.
In the US, it has been shown that targeting sample sources known to have a relatively high infection
probability in endemic areas can be a cost-effective surveillance approach (Miller et al., 2000; Samuel
et al., 2003; Walsh and Miller, 2010) and spatial targeting via risk-based assessments to focus sampling
on landscapes of highest relative risk may enhance surveillance (Bollinger, 2004; Rees et al., 2012;
Nobert et al., 2016).
3.3.2. Surveillance in Europe: past and present
3.3.2.1. In Europe
During the period 2006–2010, a survey was carried out in the EU with the aim of detecting the
possible presence of CWD and other TSE in the EU farmed and wild cervid populations, with no TSE
positive results recorded.
The framework of the survey was established by the Commission Decision 2007/182/EC (see
footnote in Section 1.1.1) on the basis of the recommendations provided by a SSC Opinion (Scientific
Steering Committee (SSC), 2003) and an EFSA Opinion (EFSA, 2004). The MS were asked to complete
the testing activities by the end of 2008.
It was recommended that:
• ’all MS should take samples for CWD from clinical/sick cervids and fallen/culled cervids, as a
priority, as well as from road-injured or killed cervids of all cervid species. The competent
authority of the Member States should endeavour to maximise awareness of these cervids and
to ensure that as many such cervids were tested for CWD as possible.
• based on sufficiently large deer populations, a subset of 13 target MS should randomly test
wild and/or farmed red deer and in Finland wild white-tailed deer were considered as
susceptible i.e. target species; all cervids should be over 18 months of age with a preference
for male animals; these MS were assigned a minimum sample size of deer to be collected
(close to 600 animals per MS in either wild or, where present, farmed cervids) based on a
design prevalence at national level equal to 0.5%.’
The criteria used to design and implement the survey along with some critical comments included
in a subsequent EFSA Opinion (EFSA BIOHAZ Panel, 2010) are summarised in Table 4.
The survey was carried out mainly between 2007 and 2009 (few samples were collected in 2006
and 2010). A total of 21 MS reported some testing activities on wild animals and 14 MS tested farmed
animals with a total of 10,109 tests in the two target species – red deer and white-tailed deer –
(including 612 animals from Norway). However, not all target MS were able to meet the minimum
sample size. An additional 2,602 other farmed/wild cervids were also submitted to rapid test (mostly
roe deer but also fallow deer, moose, reindeer or other).
As mentioned, no TSE positive results were found. A subsequent EFSA opinion (EFSA BIOHAZ
Panel, 2010) reviewed the results and concluded that there is not a cervid TSE epidemic in the EU.
However, the same opinion also concluded that, based on available data, the ‘occurrence of cases of
TSEs, especially in remote and presently unsampled geographic areas, may not be excluded in cervids
in the EU’.
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Prior to this survey, another study was carried out in wild and farmed cervid species in Germany,
which did not record any TSE positive results (Schettler et al., 2006).
Between 2011 and 2014, the testing activity in the MS (see Appendix A) was minimal. In 2015,
based on available official data from the TSE annual reports submitted by the MS to the European
Commission, only Finland and Hungary and one non-MS (Norway) reported test results for TSE in
cervids (Table 5). None of the samples tested positive. However, the number of tested animals over
the 2011–2015 period was insufficient to draw any epidemiological conclusions.
Table 4: Comparison of the features of the 2004 EFSA Opinion, 2007 EC Decision and 2010 EFSA
Opinion
Criteria EFSA (2004) 2007/182/EC Decision
EFSA BIOHAZ
Panel (2010)
Scope n/a Detection of the CWD presence in
animals of the deer family
n/a
Target disease All forms of TSE CWD n/a
Target MS n/a Wild: AT, CZ, DE, FR, UK, FI, HU,
IT, LV, PL, SK
n/a
n/a Farmed: AT, CZ, DE, FR, IE, UK n/a
Target species Red deer + white-tailed deer In target MS: red deer + white-
tailed deer
n/a
Sampling design n/a Random Not fully geographically
representative
Tests Rapid tests for BSE + IHC &
WB
Rapid tests for TSE in cattle and




Farmed + wild FS Farmed + wild n/a
Target groups Sick, FS Sick, road-killed, FS/culled, healthy
slaughtered and healthy shot
n/a
Tissue Obex (dorsal vagus
nuclei) + retropharyngeal
lymph nodes (cortex
area) + entire head
Obex (dorsal vagus nuclei) Low sensitivity when
targeting only obex
Age > 18 months of age > 18 months of age n/a
Sex n/a Males (when shot) n/a




High BSE and scrapie
incidence, exposure to
feeding stuffs, import from
areas affected by CWD
Densely populated deer areas,
high BSE and scrapie incidence,
exposure to feeding stuffs, import
from areas affected by CWD
n/a
Genotyping n/a Only if positive result obtained Lack of collection of PrP
gene polymorphism




0.5% for risk populations,
otherwise 1%
598 samples n/a
All MS n/a Target species: all cervids
Target groups: sick animals, road-
killed, culled or FS





TSE: Transmissible spongiform encephalopathy; BSE: bovine spongiform encephalopathy; CWD: chronic wasting disease;
FS: fallen stock; IHC: immunohistochemistry; MS: Member State; WB: western blot; AT: Austria; CZ: the Czech Republic;
DE: Germany; FR: France; UK: the United Kingdom; FI: Finland; HU: Hungary; IE: Ireland; IT: Italy; LV: Latvia; PL: Poland;
SK: Slovakia.
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3.3.2.2. The Norwegian TSE situation
In 1994, a cat was diagnosed with FSE (Bratberg et al., 1995). Atypical/Nor98 scrapie was first
diagnosed in Norwegian sheep in 1998 (Benestad et al., 2003) and since then 3–15 cases are identified
each year in sheep. A single case of atypical/Nor98 scrapie was diagnosed in a goat in 2005. Classical
scrapie is rare in Norway now and only six single-flock outbreaks (in 2001, 2002, 2003, 2004, 2006 and
2009) have been diagnosed during the last 15 years. In 2015, atypical BSE (H-type) was diagnosed in a
15-year-old cow of the Scottish Highland breed, which was killed due to injury (Table 6).
During the slaughter season for semidomesticated reindeer in the municipalities of Kautokeino and
Karasjok (Finnmark County), from December 2003 until February 2004, samples from 792 animals were
collected and screened for prion diseases, with negative results by ELISA analysis (Tryland et al., 2014).
Altogether a total of 2,163 cervids were found negative for CWD between 2004 and 2015 (Table 7).
















DK – – – – – – – 25
FI – 4 3 1 – 6 – –
HU – – – – – – 9 –
LV – – – – – – – 2
NO 4(1)(a) – 1(1)(a) – 8(7)(a) 4(2)(b) – –
SE – – 1 – – – – –
DK: Denmark; FI: Finland; HU: Hungary; LV: Latvia; NO: Norway; SE: Sweden.
(a): Total (wild).
(b): One of the moose tested was classified as ‘unspecified’. All test results were negative. The data were extracted from annual
reports submitted by reporting countries, and from background information provided by the European Commission and
included in the mandate.
Table 6: Number and year of detection of animal prion disease cases diagnosed in Norway










Sheep 64 (last in 2009) – 143 – –
Goat – – 1 (2005) – –
Cattle – – – 1 (2015) –
Domestic cat – 1 (1994) – – –
Reindeer (free-ranging) – – – – 3 (2016)
Moose – – – – 2 (2016)
FSE: feline spongiform encephalopathy; BSE: bovine spongiform encephalopathy; CWD: chronic wasting disease.
(a): Prior to 1998, classical and atypical/Nor98 were not distinguished, but based on the diagnostic criteria, most of the
diagnosed cases were classical scrapie.
















2004 21 11 – 1 792 10 13 848
2005 17 10 – 1 93 14 10 145
2006 9 129 – – 48 12 13 211
2007 34 612 8 – 30 35 1 720
2008 26 9 – 2 – 9 1 47
2009 31 9 – 2 – 11 – 53
2010 17 5 – 2 – 13 4 41
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This led to the conclusion that there was no CWD epidemic in Norwegian cervid populations.
However, looking retrospectively the sample size was very limited as only 10 free-ranging reindeer and
130 moose were analysed (Table 7), none of them originating from the CWD areas, and thus low-level
occurrence during this period of time cannot be excluded.
The surveillance programme put in place after the detection of CWD in reindeer and moose in
Norway has as its main goals:
• ’To get a better understanding of the distribution of the disease in the country and whether it
is really limited to the two areas of Nordfjella (reindeer) and Selbu (moose). This is being
addressed by testing found sick/dead and traffic-killed animals from the whole country.
• To determine whether reindeer and moose are the only affected species, by testing all cervid
species.
• To ascertain if CWD is only present in free-ranging species by also testing some captive
reindeer.
• To measure the frequency of the disease in the affected species in the vicinity of known cases.
This would give some information about how long the disease may have gone undetected.
This is currently addressed by targeting hunter-killed (i.e., randomly sampled) animals from the
two affected areas’.
The targeted number of cervids to be sampled was originally set as 15,000 for 2016. However, it is
expected that it will not be higher than 10,000. This is due to the substantial logistical challenges
associated with the collection of samples from free-ranging animals, and the difficult Norwegian
geographical conditions. To date (21-Nov-2016), 8,912 cervids have been analysed (Table 8): 4,264
moose, 1,785 reindeer, 2,442 red deer and 336 fallow deer.6
If the apparent prevalence in the affected areas is as low as 1%, then the prevalence in other
regions may be as low, and the chance of detecting one case would be very limited, considering the
number of animals tested. Another limitation of the current surveillance system is the poor quality of
some brain samples collected in the wild, which makes the identification of the brain stem and the
specific target area, the obex, more difficult. The sensitivity of surveillance, reliant on the collection of
brain samples only, may also be reduced in some cases if the earliest detectable accumulation of PrPSc
is in lymphoreticular tissue and not the brainstem. However, a caveat to this is that not every CWD
case presents with early lymphoid involvement (the Norwegian moose being an example), so this is
equivalent to the situation in sheep scrapie, where PrPSc can be identified early in the incubation
















2011 12 13 – 1 1 11 – 38
2012 3 10 3 – – 5 – 21
2013 4 4 1 – – 1 – 10
2014 1 4 – – – 5 – 10
2015 8 4 – 3 – 4 – 19
Total 183 820 12 10 966 130 42 2,163

















Positives – – – 3 – 2 –









CWD: Chronic wasting disease.
6 http://www.mattilsynet.no/dyr_og_dyrehold/dyrehelse/dyresykdommer/skrantesjuke__cwd_/status_paa_kartleggingen_av_skra
ntesjuke.23546
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The first case of CWD in Norway was the first case of naturally occurring CWD in reindeer
worldwide (Benestad et al., 2016), but it has been known that the species is susceptible to the disease
since researchers have reported successful oral transmission of CWD to reindeer (Mitchell et al., 2012;
Moore et al., 2016).
It is also notable that CWD cases in moose seem to be a rare occurrence in North America,
whereas two of the five CWD cases detected thus far in Norway were moose. This difference might be
due to the fact that the Scandinavian moose population is much larger than that in the parts of North
America where CWD occurs, or due to differences in CWD strains or exposure probabilities in moose
between the two continents.
Baeten et al. (2007) described a natural case of CWD in a hunted moose in Colorado. The IHC in this
case demonstrated the presence of accumulations of CWD-associated prion protein (PrPCWD) in tissue
sections of the medulla oblongata at the level of the obex (dorsal motor nucleus of the vagus) and in
retropharyngeal lymph node (RPLN). This immunolabelling is therefore indistinguishable from that
described in other CWD cases. In contrast, preliminary unpublished results from the PrPCWD
immunostaining obtained in the two Norwegian moose show clear differences. An unusual PrPCWD
distribution is found throughout the brain where the vast majority of PrPCWD is detected only
intraneuronally, and with no special labelling in the dorsal motor nucleus of the vagus. The lymph nodes,
available from only one of the two moose, were negative. The western blot glycoprofile of the PrPCWD of
the two moose show a lower molecular weight than those of other CWD isolates from different North
American species but quite similar to each other’s. A similar low molecular weight of PrPCWD has been
reported in wapiti with an M-to-L polymorphism at codon 132 (O’Rourke et al., 2007). Bioassay studies
are ongoing to verify whether these differences could reflect a new or unidentified strain/phenotype in
the Norwegian moose.
3.3.3. Control of CWD
The science available to inform effective CWD management and control strategies remains
relatively incomplete (Miller and Fischer, 2016; Uehlinger et al., 2016). Approaches for CWD
management generally fall into three categories: (a) prevention, for regions where CWD is not
believed to occur or is assumed absent; (b) containment, focused on limiting the geographic extent of
a focus; and (c) control/suppression, to actively stabilise or reduce infection rates in an affected herd
or population. Preventive and containment strategies tend to focus on regulations (e.g. bans on
movements of live animals, carcasses, or specified risk materials), whereas control/suppression tends
to be more active (e.g. selective or random culling, reduction in affected populations via harvest,
depopulation). As an overarching observation, attempts to manage and control CWD in North America
thus far have been more successful in captive situations than in free-ranging ones. Efforts to prevent
the introduction of CWD should consider whether prior surveillance data are sufficient to assure that
the disease has not already spread into the area of interest.
Eradicating CWD from North America appears infeasible, given its extensive distribution and other
epidemiological attributes. Free-ranging foci have persisted despite varied control attempts with only
two exceptions: Minnesota and New York (Minnesota Department of Natural Resources, 2016).
CWD was detected during routine surveillance in captive white-tailed deer in Oneida County, New
York State, in 2005. A further case was detected in a second captive herd that had received deer from
the first one, and both herds were depopulated. Intensive efforts were made to assess whether CWD
occurred in wild deer in the area. These included operations by a multiagency team under the Incident
Command, which ran 14 teams of sharpshooters in a 10-mile radius around the index case. Two
further cases of CWD were found in wild deer. A containment area of 850 square miles was
established, in which intensive testing and a number of activities to hinder the spread of CWD were
conducted following an emergency regulation. These included the prohibition of: (a) processing traffic-
killed deer by private citizens, to make the animals available for testing; (b) rehabilitating deer at
facilities housing cervids and (c) moving animal parts or deer urine out of the area. The testing of
hunter-killed deer in the containment area in the 2015 hunting season was made compulsory, and
waste from deer carcasses was disposed of in a landfill. The sale of white-tailed deer feed was
prohibited in the whole state. Capture and possession of free-ranging white-tailed deer by deer or
wapiti farm owners, or taxidermists working with deer or wapiti, was also forbidden. New requirements
for reporting and record-keeping were implemented for taxidermists (Brown et al., 2006). In the
5 years following the detection of the first case of CWD in New York State, 7,335 deer from the
containment area and 21,867 from the rest of the state were killed and tested (New York State
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Department of Environmental Conservation, 2013). Surveillance has continued since then and no
further cases have been detected to date.
Intensive surveillance and culling leading to apparent elimination or to an undetectable level of the
infection were also applied in Minnesota, where one case of CWD was found in a wild white-tailed deer.
More than 4,000 deer were tested in the area where the case was confirmed from 2011 to 2013. No
further cases were detected until autumn 2016 (Minnesota Department of Natural Resources, 2016).
These experiences underscore the importance of early detection and intervention. Once CWD is
well-established and has become endemic in the cervid population and the environment, elimination is
considered unattainable. In these circumstances, controlling the spread – in particular by human
activities – and suppressing infection rates seem far more realistic goals than eradication.
Even where eradication is infeasible, combinations of intensive focal deer removal and more
sustained herd suppression may offer some measure of control (Manjerovic et al., 2014; Geremia
et al., 2015; Nobert et al., 2016). Acquiring reliable distribution and prevalence data early on may
improve the efficacy of subsequent CWD control efforts (Miller and Fischer, 2016). Jurisdictions should
also consider how cervid population management practices (e.g. harvest regimes, artificial feeding and
congregating, translocations or movements in commerce), may be contributing to disease emergence
or persistence (Miller and Fischer, 2016).
In Europe, in addition to the permanent measures as described in Appendix A, the Commission
Implementing Decision (EU) 2016/19187 enforces temporary safeguard measures in relation to CWD
(until 31 December 2017), subject to review of the epidemiological situation and of the necessity of
the prohibition.
• According to Article 2.1 of the Commission Implementing Decision, the movement of live
cervids from Norway into the Union is prohibited from 28 October 2016.
• According to Article 2.2, by way of derogation from paragraph 1, the following movements of
live cervids are permitted:
– movements of live reindeer for seasonal grazing from Norway to the areas in Sweden
listed in the Annex of the Commission Implementing Decision, or back to the areas in
Sweden listed in the Annex the Commission Implementing Decision after seasonal grazing
in Norway, provided that the competent authority of Sweden gives its prior written
consent to such movement;
– movements of live reindeer for seasonal grazing from Norway to the areas in Finland listed
in the Annex of the Commission Implementing Decision;
– movements of live reindeer from Finland which have grazed in Norway in the area located
between the Norwegian- Finnish border and the Norwegian-Finnish Reindeer Fence and
return to Finland;
– movements of live cervids from Norway to Sweden or Finland for direct slaughter,
provided that the competent authority of the Member State of destination gave its prior
written consent to such movement;
– movements of live reindeer from Norway to the areas in Sweden listed in the Annex the
Commission Implementing Decision for sportive or cultural events, or after having taken
part in sportive or cultural events, provided that the competent authority of Sweden gives
its prior written consent to the movement of each consignments;
– transit of live cervids from Norway through Sweden or Finland and destined to Norway,
provided that the competent authority of the Member State of transit gave its prior written
consent.
By way of derogation, the dispatch of live cervids for direct slaughter from certain areas in Sweden
to the rest of Sweden or to Finland and from certain areas in Finland to Sweden or to the rest of
Finland are permitted, provided that the competent authority gives prior written consent. Equally, the
dispatch of live cervids from certain areas to Norway is permitted provided that the competent
authority of Norway gave its prior written consent.
7 Commission Implementing Decision (EU) 2016/1918 of 28 October 2016 concerning certain safeguard measures in relation to
chronic wasting disease. OJ L 296. 1.11.2016, p. 21–24.
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3.3.4. Cervid populations in the concerned countries
3.3.4.1. Cervid populations – wild/free ranging
The numbers of individual animals in free-ranging wildlife populations could not be accurately
ascertained, so, estimates of population size are presented in Table 9. There is not a single best method
to estimate population density and/or abundance. Both direct (for example, direct counts) and indirect
methods (for example, counting dung) can be used and the choice of method depends on local
conditions, habitat, resource availability, accuracy requirements and other factors. Hunting statistics can
provide information on population abundance, in particular at large spatial scales, such as at country
level, and also on their long-term temporal trends, provided that the hunting effort is maintained.
Since diverse population estimation methods are used according to the circumstances and in
different countries, and also for different cervids species, direct comparison of such data is not reliable.
The figures on population abundance provided in Table 9 have been obtained from different
sources and represent various methodologies used for census and estimates. Additionally, some of the
data are several years old since more recent data could not be obtained, and the actual population
size may have changed since the data were recorded. Therefore, the population data presented may
be incomplete or outdated, reflecting the difficulties stated. Hunting statistics presented in Table 9 are
mostly sourced from national official statistics websites.
These data are presented to illustrate the diversity in population sizes, by species, for the various
countries under consideration, and to demonstrate how difficult it is to obtain/estimate such data.
Table 9: Total number of hunted and estimated wild population of the cervid species of interest in the
countries covered by the mandate
Species Reindeer (wild) Moose White-tailed deer Roe deer Red deer Fallow deer
Sweden-population 0 300,000(c) Occasional 350,000(r) 35,000(r) 130,000(r)
Sweden-hunted 0 87,094(d) 0 106,024(d) 7,751(d) 30,382(d)
Norway-population 25,000(a),(e) 120,000(f) 0 150,000(f) 125,000(q) Very few
Norway-hunted 6,507(a),(e) 31,137(e) 0 19,996(e) 33,799(e) 0
Finland-population 2,555(b),(g) 54,187(g) 46,162(g) 30,000–50,000(p) 0 612(g)
Finland-hunted 18(b),(h) 44,122(h) 26,578(h) 4,771(h) 0 61(h)
Estonia-population 0 13,500(i) 0 46,400(i) 3,260(i) 0
Estonia-hunted 0 6,873(j) 0 6,264(j) 1,252(j) 0
Latvia-population 0 21,700(k) 0 133,200(k) 53,200(k) 0
Latvia-hunted 0 5,810(k) 0 13,170(k) 11,805(k) 0
Lithuania-population 0 10,903(l) 0 111,427(l) 30,056(l) 2,325(l)
Lithuania-hunted 0 8,660(m) 0 109,707(m) 25,672(m) 1,631(m)
Poland-population 0 11,714(n) 0 829,000(n) 203,000(n) 27,225(n)
Poland-hunted 0 0(n) 0 166,889(n) 60,307(n) 7,042(n)
Iceland-population – 0 0 0 0 0
Iceland-hunted 1,291(o) 0 0 0 0 0
(a): Wild Eurasian tundra reindeer (Rangifer tarandus tarandus).
(b): Finnish forest reindeer (Rangifer tarandus fennicus).
(c): http://jagareforbundet.se/vilt/vilt-vetande/artpresentation/
(d): https://rapport.viltdata.se/statistik/2014/2015
(e): Eurasian tundra reindeer (R. t. tarandus) (2015) http://www.hjorteviltregisteret.no
(f): VKM (2016). CWD in Norway. Opinion of the Panel on biological hazards, ISBN: 978-82-8259-216-1, Oslo, Norway.
(g): https://riistaweb.riista.fi/riistatiedot/riistatietohaku.mhtml Report of population left (after hunting), for year 2015.









(p): Mr Jyrki Pusenius, Natural Resources Institute Finland, confirmed this by email on 21 November 2016.
(q): Solberg et al. (2008).
(r): Mr Jonas Malmsten, Viltkonsult Jonas Malmsten AB, confirmed this by email on 21 November 2016.
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3.3.4.2. Cervid populations – captive and farmed
Cervids are also kept in captivity in deer farms, animal parks, zoological gardens and other
holdings. Farmed cervids in the countries concerned are mostly red deer and fallow deer. Smaller
numbers of cervids are kept in parks for educational purposes, recreation and tourism, for example,
moose parks. Data on the captive cervid populations in the countries were not readily available and
therefore are not presented in this opinion.
3.4. Ecology and husbandry of wild, semidomesticated and farmed
cervids in Fennoscandia8
Cervids are deer species of the family Cervidae. Cervids have played important roles throughout
human history, representing important sources of meat and materials. In addition to reindeer herding,
wild cervid populations are very important to the region, especially as a source of recreational hunt,
and hunting is also the most effective management and control measure in the cervid populations of
these regions.
Cervids are ruminant plant eaters. Some species feed mostly on the ground (grazers) and others on
trees and bushes (browsers). The choice of feed will to a large extent depends on the local
ecosystems and availability, and usually also varies throughout the year. Reindeer are gregarious
animals, forming large herds, whereas the other cervid species in question mostly live in smaller
groups or are solitary animals. Cervids, such as reindeer, may also conduct seasonal migrations,
sometimes over large distances, and sometimes between summer and winter habitats on a more local
scale.
In the following sections, the ecology and husbandry of wild and semidomesticated cervids in
Fennoscandia are described. Due to shortage of time, similar information for other regions and
countries included in the mandate have not been collated and described in this opinion.
3.4.1. Wild cervid populations
3.4.1.1. Eurasian tundra reindeer and Finnish forest reindeer
Reindeer are mostly grey to brown in colour, and, in contrast to all other cervid species, both sexes
have antlers, which are shed after the rut in October (males) or later during winter and spring
(females). Reindeer give birth to one calf (twin calves are extremely rare) in late April to early June.
They become sexually mature at approximately 1.5 years of age, females usually giving birth as a
2-year-old. Reindeer vary considerably in size, both between and within the different subspecies and
their geographical range. The body length of reindeer may reach 220 cm from nose to tail, a wither
height (height of the ridge between the shoulder blades) of 125 cm and a body weight of 270 kg for
large males, whereas females are considerably smaller. In winter, as much as 40–80% of the food may
be lichens (Cladina spp. and others), whereas in summer they eat grass, sedges, herbs and some
shoots and leaves, depending on habitats and availability. In general, food is plentiful in summer, but
often limited on winter pastures.
Reindeer, commonly called caribou in North America, all belong to the same species,
Rangifer tarandus. This species is divided in seven subspecies, of which only two are relevant to this
report: the Eurasian tundra reindeer (R. t. tarandus) and the Finnish (Eurasian) forest reindeer
(R. t. fennicus).
The Eurasian tundra reindeer is almost continuously distributed in Eurasia, across the tundra region
and mountain areas, and may in some places overlap with the Finnish forest reindeer. This subspecies
comprises the cornerstone of the reindeer herding industry and cultures, as semidomesticated
reindeer, in mainland Norway, Sweden, Finland and parts of Russia. This subspecies is also found as
wild reindeer in Norway, comprising 23 separated populations of approximately 25,000 animals in total
(Figure 2). Of these, the Hardangervidda population is the largest, with about 10–11,000 animals.
8 Nordic region comprising Finland, Norway and Sweden in their entireties as well as Murmansk Oblast, much of the Republic of
Karelia and parts of northern Leningrad Oblast in Russia (www.wikipedia.org)
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Wild reindeer usually conduct seasonal migrations between summer and winter pastures, although,
for some of the populations, infrastructure (e.g. roads and railways) and natural boundaries (e.g.
rivers, lakes and valleys) limit such migrations to a large extent.
The wild reindeer population in the Nordfjella region (Figure 2, region 11), in which the three CWD
cases up to now have been detected, is estimated to consist of approximately 2,500 animals, and is
restricted to an area of 2,995 km2 region north of the Hardangervidda mountain plateau. During the
18th and 19th centuries and into the first half of the 20th century, there was also reindeer herding
(i.e. semidomesticated reindeer) in several regions of what today is defined as the Nordfjella wild
reindeer region, with frequent mingling between wild and semidomesticated reindeer (Figure 3), and
there is still some exchange of animals between wild and semidomesticated reindeer herds today
(Strand et al., 2011). The status and development of the 23 different wild reindeer populations in
Norway varies. The harvest from the Nordfjella population during the last 6 years has varied from 266
animals in 2012 to 522 animals in 2014 (mean 2012–2014: 448) (www.hjorteviltregisteret.no).
Some of the wild reindeer populations, but not the Nordfjella population, are included in the
national surveillance programme for deer species of the Norwegian Institute for Nature Research
(NINA) (http://www.nina.no/english/Home). Some investigations on health and diseases have been
conducted through the surveillance programme for cervid health of the Norwegian Veterinary Institute
(NVI) (http://wwweng.vetinst.no/eng/index.html). There are no previous reports of diseased reindeer
with CNS symptoms from the Nordfjella population.
The Finnish forest reindeer is found in two defined populations in Finland, as well as in Russia, but
it remains unresolved whether reindeer of other forest regions should also be included within the same
subspecies. This subspecies is larger than the tundra reindeer, has longer legs and narrow v-shaped
antlers, and prefers boreal forest habitats.
The three clinical cases (up 21 November 2016) of CWD have all been detected in Nordfjella (region 11). (http://
www.nina.no/english/Home).
Figure 2: Distribution of the 23 populations of wild Eurasian tundra reindeer of Norway. Source:
Norwegian Institute for Nature Research
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3.4.1.2. Moose
Moose (A. alces) is further divided into several subspecies. In Europe, they are therefore sometimes
called Eurasian moose or Eurasian elk/European elk (A. a. alces), which is mostly distributed in
Finland, Sweden, Norway, Latvia, Lithuania, Estonia and Russia. In Norway, moose were previously
restricted to the southern and eastern parts of the country, but during the past decades have spread
to most parts of the country (Figure 4).
Map: Bernt Johansen, Norwegian Research Institute (NORUT).
Figure 3: Distribution of the Nordfjella wild reindeer population (red), where the three CWD cases
had been found, and the borders to the Hardangervidda wild reindeer population (dark
green) and the neighbouring herd of semidomesticated reindeer (pink)
Figure 4: Number of moose shot in Norway per 10 km2 hunting area (2016), and geographical
distribution. Source: Statistics Norway (https://www.ssb.no/en/jord-skog-jakt-og-fiskeri/sta
tistikker/elgjakt)
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The moose is the largest cervid species (males 400–550 kg and females 320–400 kg) and may
reach an age of 15–25 years. It is brown to grey in colour and only males have antlers. They are
commonly found in boreal coniferous and deciduous forests in temperate and subarctic regions in the
Northern hemisphere. However, they may also exist in many other habitats, including regions with a
mountainous and alpine character. Moose are solitary animals, with strong bonds between mother and
calves, but dozens of animals may be observed together, especially during winter, when they
congregate for feeding or under heavy snow conditions to save energy. The total winter population of
moose in Norway is about 120,000 animals (Table 9).
Males are polygamous, serving several females during the mating season. Moose usually give birth
to one or two calves in May–June. The most common predators of moose in Fennoscandia are the wolf
(Canis lupus lupus) and the brown bear (Ursus arctos). Moose hunting is a very popular activity, with
long traditions in many regions and is the main regulator of the populations, as predator numbers are
generally low. The harvest of moose in Norway has been stable over the last decade, and
approximately 32,000 animals were shot annually during 2005–2015 (www.hjorteviltregisteret.no).
Moose are selective feeders. In spring/summer, they typically not only feed on fresh shoots of
deciduous trees and shrubs and herbs but also on fresh grass, and in winter, they mostly feed on older
branches, including pine trees. During summer, a full-grown moose may eat as much as 50 kg of
biomass each day in summer, but only 8–16 kg of biomass per day in winter, when the metabolism is
lower. During winter, an adult moose may lose 20–25% of its body weight (www.hjorteviltregisteret.no).
A moose may spend large amounts of energy seeking food, and the hair coat on the legs and the sides
of the animal may be worn out. This sign is often found along with emaciation (lack of fat resources,
i.e. subcutaneous, intraabdominal, coronary grooves and bone marrow).
Since 1985, a wasting syndrome (moose wasting syndrome (MWS), also called €Alvsborgsjukan) has
been observed throughout Sweden, but with an elevated occurrence in the county of €Alvsborg, with
clinical symptoms resembling CWD. More than 1,000 moose were found dead or euthanised in this
county by the end of 1992 (Merza et al., 1994).
This condition is characterised by starved and emaciated animals with a lack of normal fight
behaviour, ataxia, lack of coordination and circling. The aetiology of MWS is unclear (Frank, 2004).
Investigations of brain material from affected animals for histopathological alterations revealed no
spongiform changes, characteristic of prion disease, and the immunohistochemical analysis for prion
protein aggregates was negative. Brain areas investigated included the forebrain, cerebellum and,
most importantly, the brain stem at the level of the obex. Based on this, it was concluded that MWS
was not caused by a prion agent like CWD (Rehbinder et al., 1991). A retrovirus was previously
isolated from diseased moose thought to cause the wasting syndrome (Merza et al., 1994), but this
has gained little support as the only cause of the syndrome. Other hypotheses regarding the aetiology
have been numerous, among others, several types of nutritional deficiencies (Frank, 1998).
3.4.1.3. Roe deer
Among the cervid species included in this scientific opinion, the roe deer is the smallest (18–36 kg)
with a wither height of 70–85 cm. The roe deer was almost extinct in Scandinavia around 1830, but is
again abundant in the region covered by this report, and has expanded into new regions. Roe deer not
only inhabit agricultural land and grass lands, but also different types of forest ecosystems, feeding on
grass, sedges and berries, as well as grain, heather, leaves and young shoots. Only the males grow
antlers. They use small trees to clean the velvet from new antlers (April–May) and to mark territory
during the rut (August). The antlers are shed in November–December, and new velvet-covered antlers
are soon established. Roe deer is an important game species in Europe (see Table 9).
3.4.1.4. White-tailed deer
White-tailed deer is a medium-sized cervid species, native to the United States, Canada, Mexico,
Central America, and South America, and is the most widely distributed wild ungulate in America. This
species has also been introduced to a wide range of other countries, including some European
countries, such as Finland, the Czech Republic and Serbia. In 1934, four white-tailed deer, three
females and one male were imported to Finland, as a gift from Minnesota, USA. Since then, this
population has grown tremendously, to approximately 25,000 animals, and is today one of most
economically important game species in Finland, second only to moose (Table 9). The Finnish
population is isolated from other white-tail deer populations (Kekkonen et al., 2016).
In Finland, white-tailed deer feed mainly on grass, shoots and leaves in deciduous forest habitats.
They may also eat feed associated with farms, and, in Finland, white-tailed deer are often and to a
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large extent fed through the winter, with hay or ensilage. Feeding spots for white-tailed deer are also
often visited by other cervids, and may thus be a very important contact point between animals and
species with regards to the potential transmission of CWD.
3.4.1.5. Red deer
The red deer is distributed in most parts of Europe, the Asian part of Turkey, the Middle-East, Asia
and North Africa. A full-grown male can have a body length of 260 cm, a wither height of 150 cm and
weigh up to 250 kg. The female typically weighs around 120 kg. Red deer can live longer than
20 years in captivity, but rarely grow older than 10 years in the wild. The hair coat of red deer is short
and brown in summer, but in winter the guard hair becomes longer and greyer. In summer, red deer
mainly feed on grass and sedges. In winter, they still prefer grass, if available, but also feed on
heather and other plants on the ground, as well as shoots and branches from deciduous trees. Red
deer females give birth to one calf (7–10 kg) in May, and feed the calf for about 7 months. Only males
grow antlers, which are shed in April–May, followed by growth of new antlers.
Wild red deer can live solitary lives or they can form smaller herds of a few animals or some dozens
of animals. Some animals tend to stay in the same area all year around, whereas others migrate
between summer and winter pastures, usually from lowlands and forest areas on the coast and
through valleys, reaching more mountainous ecosystems in the spring, summer and autumn.
The harvest of red deer in Norway has been stable over the past years and on average, approx.
33,700 animals were shot annually in Norway during 2011–2015 (www.hjorteviltregisteret.no). Red
deer is also an important game species for the other countries relevant to this report (Table 9).
Wild red deer can be infected with gammaherpesvirus, known to cause malignant catarrhal fever (MCF) in
cattle, and having sheep as a reservoir. This may be relevant, since this infection may generate CNS signs,
such as abnormal behaviour, apathy, incoordination, circling, staggering gait, convulsions and impaired vision
(Vikøren et al., 2006). In a screening in Norway, 5% (13 animals) had antibodies against gammaherpesvirus.
3.4.1.6. Fallow deer
The fallow deer is native to western Eurasia, but has been introduced to numerous other countries.
In Norway, wild fallow deer originate from individuals that have escaped from deer farms, and a small
population has settled on Hankø Island (Østfold County) and individuals are sometimes observed east
of the river Glomma (Hedmark County), but this species is numerous in Sweden and represents an
important game species (Table 9). A fallow deer is smaller than the red deer but larger than the roe
deer. An adult female fallow deer (> 3 years) weighs about 40–65 kg and an adult male (> 5 years)
weighs approximately 80–120 kg. Fallow deer have characteristic white spots on the sides and over
the back. Only males have antlers, which are shed in April–May. After approximately 8 months
pregnancy, one calf is born. Females and calves typically form their own groups in other periods of the
year than the rut, which starts in October–November, when males may fight and gather a harem of
females. Fallow deer are found in open agricultural land with grass pastures in spring and summer, but
usually prefer forest during autumn and winter to seek more shelter, and to feed on nuts, berries and
bark. They are regarded as more stationary compared with other deer species.
3.4.2. Semidomesticated reindeer
Herded reindeer are not wild, since they are owned, and most of them are gathered a few times
during the year for slaughter, or tagging and transport between summer and winter pastures. But they
are not regarded as domesticated, as compared with cattle, sheep and goats, since they are always
outdoors, most of the time as free-ranging animals. Herded reindeer are therefore commonly referred
to as semidomesticated.
Except for a few smaller regions in Finland inhabited by wild Eurasian forest reindeer, all other
reindeer in Fennoscandia (Norway, Sweden, Finland and Kola Peninsula, Russia) belong to the Eurasian
tundra reindeer subspecies. Except for the 23 wild reindeer populations in southern Norway, and the
forest reindeer in Finland, all other reindeer in Fennoscandia are herded, i.e. semidomesticated.
In Fennoscandia, reindeer herding is a traditional cornerstone of the Sami culture. In Norway and
Sweden, only people with a Sami heritage can own reindeer, whereas in Finland, there are both Sami
and non-Sami reindeer herders. In Russia, the Sami people are one of many indigenous people that
live from reindeer herding, often combined with fishing, hunting and trapping. The area traditionally
inhabited by the Sami people, which grossly also reflects the core region of the reindeer herding, that
in Sami is called Sapmi (Figure 5).
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Reindeer feed on many different plants during summer, depending on the local habitats and
resources, and they have shown a great ability to adapt to changing environments. The summer
pastures support most of the production (i.e. the calves) whereas the winter pastures, often high
mountain plateaus, such as Finnmarksvidda in Norway, often consists of lichens and other plants with
poorer nutritious content, which represents maintenance feed, with carbohydrates for winter survival
but little protein for growth. The winter pastures are often the restricting resource during the herding
year, determining how many animals the herder/pasture can maintain. Semidomesticated reindeer
were traditionally kept in a seminomadic way, shifting between winter and summer pastures. This
practice was, however, challenged when the country borders were drawn in the northern regions
during the 18th century, shutting down some of the traditional coast – inland migration. However, such
migrations are still used in many regions of Norway and some places in Sweden, where animals are
either herded by foot, or transported by car or boat between summer and winter pastures, whereas in
other parts of Sweden and in Finland, animals are kept at the same pasture year around, and feeding,
either as supplementary feeding or on a daily basis, becomes more and more common (Figure 6).
In Norway, the total number of semidomesticated reindeer is about 211,000 animals (Table 10).
Reindeer herding is organised in six reindeer pasture regions, namely Øst-Finnmark, Vest-Finnmark,
Troms, Nordland, Nord-Trøndelag and Sør-Trøndelag, with approximately 80 herding districts, each
consisting of several reindeer herding units (i.e. siida) for summer and winter pastures, respectively
(Figure 7).
For the reindeer herding year 2014–2015, 3,150 persons were registered with a siida unit. A total
of 69% of the semidomesticated reindeer in Norway are found in Finnmark County, whereas 11,065
animals are found in Troms, 14,465 in Nordland, 14,031 in Nord-Trøndelag, 13,024 in Sør-Trøndelag
and Hedmark Counties, and 12,640 in the non-Sami herding units (‘tamreinlagene’). Of these animals,
79% were females, 5% males and 16% calves. The mean carcass weight was 18.7 kg (calf), 29.7 kg
(female > 2 year) and 43.8 kg (male > 2 year). Due to differences in natural pasture resources, animal
density, and loss of animals (predators, road kill, etc.), the annual production of meat per female
animal in the herd varied between districts, from almost nothing to up to 16.4 kg (Anonymous, 2016).
Figure 5: The Sapmi region, the part of Fennoscandia traditionally inhabited by the Sami people, and
where the majority of the reindeer herding of this region is conducted. Source: (http://
www.sim1.se/background/samer/samer_01.html)
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In Sweden, reindeer herders are organised in a ‘sameby’, which is an economic and administrative
unit in a given region (the parallel to ‘siida’ in Norway). There are 51 such units in Sweden. Reindeer
pastures all together constitute approximately 50% of the land area of Sweden.
The reindeer herding units are designated to specific summer and winter pastures. A reindeer
herder may share winter pastures with 5–10 other herds, and summer pastures with these and/or
other herds. In a recent questionnaire about the disease keratoconjunctivitis in reindeer among
reindeer herders in Norway and Sweden (63 respondents), almost 30% reported that their animals
had contact with as many as 25 other herds or more during a year by sharing pastures, corrals
transport vehicles, etc. (Tryland et al., 2016).
Between Norway and Sweden, cross-border herding takes place, with many herders having pasture rights on both
sides (Source: Pape and L€offler, 2012; © Royal Swedish Academy of Sciences).
Figure 6: Reindeer herding in Norway, Sweden and Finland, indicating the development of reindeer
numbers the past century, the stocking density (animals/km2) and the seasonal migration in
the spring (arrows) or year-round pastures (circles)
Table 10: Some key features of reindeer herding in Norway, Sweden and Finland (2014–2015)
Norway(b) Sweden(c) Finland(d) Total
Number of animals(a) 211,606 250,332 194,652 656,590
Animals slaughtered/year 75,382 56,333 84,997 216,712
Reindeer meat/year (31,000 Kg) 1,748 1,459 2,000 5,207
Land area used as reindeer pastures (%) 40 50 36 –
(a): Reindeer heads in spring 2015 (after slaughter, before calving).
(b): Ressursregnskap for reindrift 2014–2015; Landbruksdirektoratet, Norway (Anonymous, 2016).
(c): Sametinget, Sweden (https://www.sametinget.se/statistik_rennaring).
(d): Reindeer Herders’ Association (Finland) http://paliskunnat.fi/reindeer
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Although reindeer herding is organised in a siida or sameby, animals in most districts are free
ranging and without daily inspection. They can also be left without observation for longer periods to
avoid disturbances, such as during calving. Although fences are sometimes used to limit mingling
between herds, these are generally not common in Norway and parts of Sweden. Thus, reindeer of
different herds will be in contact and to some extent intermingle. It is also common to exchange
animals across herding unit borders, by foot and also over longer distances by road or boat transport.
Further, reindeer owners often have to transport animals for slaughter for longer distances. Thus,
during natural herding conditions, there will be contact between reindeer of different herds, both
neighbouring and geographically more distant.
The nature of reindeer herding in Fennoscandia, using vast land areas, migrating between summer
and winter pastures, crossing municipality-, county- and country borders, the large degree of contact
between herds, and the fact that free-ranging animals may not be observed closely for long periods of
time are regarded as highly relevant factors for the epidemiology and control of CWD, should this
disease enter the reindeer herding industry.
3.4.2.1. Shared habitats and contact between free-ranging cervid species in Norway
The different cervid species have somewhat differing dietary preferences and these may change
during the seasons. Searching for food, together with seeking shelter and safety, are important drivers
of animal movement and seasonal migrations. Free-ranging cervids generally have a restricted energy
uptake during winter, and in the spring, they seek pastures and regions with an early onset of
Map: Bernt Johansen, NORUT. Reindeer herding is conducted in 140 municipalities in Norway, using around
140,000 km2 or about 40% of the land area.
Figure 7: Reindeer herding areas of Norway (semidomesticated reindeer; red areas)
Chronic wasting disease (CWD) in cervids
www.efsa.europa.eu/efsajournal 41 EFSA Journal 2017;15(1):4667
greenery, such as in coastal and low land regions. It is thus common to see cervids of different types
feeding on farmland pastures that are free of snow early in the spring. In summer, domestic animals,
such as sheep and goats, graze more and more at higher altitude and mountainous pastures, thus
increasing the potential for contact with wild cervids. Some free-ranging cervids, such as moose, may
also visit farmland during winter and feed upon silage bales.
Feeding wild cervids, such as roe deer and red deer, is rather common in the countries considered in
this scientific opinion. The purpose of this may be to keep animals away from traffic points and busy
roads but also to increase the number of animals that survive the winter. If winter feed is made available
in a sheltered spot, moose, red deer and roe deer may have greater contact than would normally occur
through natural feeding. Such feeding areas should be considered as potential environmental hot spots
that could facilitate direct and indirect transmission of infectious agents, including prions and CWD.
3.4.3. Farmed cervids
In Sweden, both fallow deer (imported) and red deer (indigenous) are farmed, but most of the
farmed cervids (80%, 2005) are fallow deer. Today, there are approximately 270 deer farms in
Sweden, keeping about 30,000 animals (http://www.fedfa.org/en/fedfa-org.-data/member-countries/
sweden-2767771). Tuberculosis, caused by Mycobacterium bovis, was identified in farmed fallow deer
in 1991 and the source of infection was traced back to an import of fallow deer in 1987. At least 13
farms with fallow deer were affected, and a TB programme was implemented. Meat inspection became
compulsory for farmed fallow deer in 1990 and for hunted red deer and fallow deer in 1994 (B€olske
et al., 2006).
In Norway, cervid farming started during the 1980s, and today, approximately 80 cervid farms are
in production, distributed mostly in the southern part of Norway, north to Fauske in Nordland County,
including about 8,400 animals (http://www.hjortesenteret.no). In 2013, deer farmers were responsible
for providing the Norwegian market with nearly 170 tonnes of venison (http://www.fedfa.org/en/fedfa-
org.-data/member-countries/norway-2767748). Most farms have red deer, but some keep fallow deer,
or in a few cases, both species. It is common to shoot farmed cervids inside the fence, bleed and
transport them to special facilities that do not normally slaughter farmed animals for carcase dressing.
Farmed cervids are kept in enclosures and normally do not have contact with free-ranging cervids,
but during the mating period, wild males may be able to enter enclosures to get access to females.
Captive deer may escape enclosures, which is how the wild population of fallow deer was established
in Norway.
4. Answers to the ToRs
4.1. Answer to Term of Reference 1
The proposed surveillance system for the concerned countries is based on the experience of CWD
surveillance in North America and the knowledge of the structure and management system of the
cervid population of some of the concerned countries, in particular Norway and Sweden.
The aims of the proposed surveillance system is twofold: (a) to detect disease in countries where
CWD has not yet been detected using a predefined design prevalence based on previous known
occurrence in newly infected areas in NA; (b) to estimate prevalence in areas where disease has been
detected.
The proposed surveillance system is intended to overcome the shortcomings highlighted in the
evaluation of the previous surveillance programme implemented in Europe 2006–2010, where it was
concluded that there was not full geographical coverage, and some species were under-represented
(EFSA BIOHAZ Panel, 2010). The sampling strategy applied in it did not take into account the known
clustered and uneven distribution of the disease, resulting in foci in which the disease prevalence is
higher. A multiyear surveillance programme may be the best strategy to effectively address the
potential for an emerging disease with expected initial low prevalence and clustered distribution.
Based on the above, the surveillance system is proposed to be implemented during a 3-year cycle,
using a combination of random and convenience sampling. This would help to address the problems
encountered by the previous scheme where an extension of a second year was required in order to
achieve the targeted sample size. This will also contribute to ensuring geographical representativeness,
which was another identified shortcoming of the previous scheme.
A further refinement of the proposed surveillance system is that it is tailored specifically for two
different management systems: farmed and wild/semidomesticated cervids.
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A two-stage sampling programme is proposed based on the application of random sampling at the
first stage (for wild/semidomesticated cervids the ‘primary sampling units’ (PSU) will correspond to
geographical areas containing cervid populations, whereas for farmed cervids they will correspond to
farms) and the application of convenience sampling within PSU corresponding to high-risk animals
(found dead, hunted or slaughtered animals considered not fit for human consumption, road/predator
kills and animals killed because they are sick or in poor body condition and not fit for human
consumption) of any selected species at the second stage. PSU may be defined as subsets of the
population based on the geographical aggregation of animals or the outputs of national RA. Since
there is no prior knowledge of differences in species susceptibility (with the exception of fallow deer
which is likely to have reduced susceptibility to CWD) and multiple species coexist within primary
sampling units, all species could contribute. However, a subset of these species may be selected based
on the outputs of national RA.
The characteristics of the proposed surveillance programme for wild cervids, semidomesticated
reindeer and farmed cervids in the countries covered by the mandate are displayed in Table 11 below.
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A proper (qualitative/quantitative) RA to estimate the likelihood of introduction of CWD into the EU
taking into account primarily movements of live cervids across the border is necessary. Surveillance
activities would be better designed after considering the outputs of such RA.
4.2. Answer to Term of Reference 2
• There are many factors that influence the ability of any TSE agent to infect a host, regardless
of whether the infection occurs across a species barrier. Currently, there is no experimental
model that encompasses all the potential host and agent variability to directly assess zoonotic
potential for any animal prion disease, including CWD.
• Although CWD has been transmitted to squirrel monkeys, in vivo transmission of CWD to other
animal models, including macaques and humanised mice, has not yet been reported.
• New evidence shows that in vitro amplified CWD can convert human PrP by PMCA. Experiments
using RT-QuIC also suggest that at the level of protein–protein interactions the molecular
barrier preventing transmission of CWD to humans may be less robust than previously thought.
• Based on the previous two bullet points, there is no evidence of an absolute species barrier
between CWD-affected cervids and humans.
• CWD strains, their prevalence, host range and zoonotic potential remain incompletely
understood. All currently available data pertaining to host range and human risk are derived
from isolates from cases of CWD identified in North American cervid species. Preliminary
evidence from the Norwegian CWD cases raises the possibility that European and North
American isolates are different.
• CWD prions are present in the skeletal muscle and other edible tissues which means that
humans may consume infected material in enzootic areas.
• There are no data on the effective infectious ‘dose’ of CWD for humans, or how that might
vary by agent strain/host species. The level of oral exposure is largely determined by the
prevalence of animal TSE and by the amount of infectivity in animal tissues entering the food
chain. The latter is reduced for BSE and scrapie by the specified risk materials (SRM)
measures, but such measures are not mandatory for cervids consumed in North America.
• From the epidemiological investigations carried out to date, no association has been made
between the occurrence of sCJD in humans and exposure to CWD. Surveillance of sCJD
indicates that the mean overall annual mortality rates are relatively consistent at 1–1.5 cases
per million in both Europe and North America.
4.3. Answer to Term of Reference 3
4.3.1. Additional animal health risk-based measures to prevent the introduction
of CWD into EU cervid populations
In order to propose risk-based measures, an accurate knowledge of the epidemiological situation of
the disease and a RA to estimate the likelihood of introduction of CWD into the EU would be
necessary. This exercise would consider the most likely routes of introduction and spread so that the
transmission pathways are identified and ranked based on their likelihood.
Although not a requirement of this mandate, a preliminary RA has been performed in a qualitative
fashion by reviewing what is known about the husbandry of wild, semidomesticated and farmed
cervids in Norway, the mechanisms of natural transmission, the epidemiology of the disease and risk
factors associated to the introduction, persistence and spread of CWD, and the review of past and
present surveillance and control measures in North America.
It was concluded that the most likely pathway of introduction of CWD into the EU is the movement
of live cervids, either by deliberate transportation or by the movement of wild animals across the
border of Norway to Sweden or Finland.
Although CWD has not been detected in semidomesticated reindeer, it is known that
semidomesticated reindeer and wild cervids have overlapping habitats. Thus, husbandry practices
applied through semidomesticated reindeer herding that could increase the risk of introduction of CWD
in to the EU via Sweden and Finland must be considered when proposing preventive measures for
introduction of CWD into the EU.
Based on the above and the current uncertainties of the actual distribution of the disease in
Norway, the following options are for consideration:
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• Since it was concluded that the most likely pathway of introduction of CWD into the EU is the
movement of live cervids, the current derogations of Article 2.2 of the Commission
Implementing Decision (EU) 2016/1918 (see details in Section 3.3.3), currently present a risk
of introduction of CWD into the EU. The probability of the introduction of CWD into and spread
within the EU associated with the movement of live cervids for direct slaughter is considered to
be lower than situations in which live animals are translocated for other purposes. Minimising
movements of live cervids would reduce the probability of introduction of CWD into the EU.
• The use of natural cervid urine lures is considered to increase the probability of introduction of
CWD into the EU, hence discontinuing its use would reduce the probability of introduction of
CWD into the EU.
• Compliance with recommendations included in awareness campaigns targeting both local
Norwegian hunters, and hunters visiting Norway from (and returning to) other countries, with
regard to personal protective equipment (PPE), disinfection, the safe dressing of carcasses and
the appropriate disposal of carcase trimmings, would reduce the probability of introduction of
CWD into the EU.
4.3.2. Additional animal health risk-based measures to prevent the spread of
CWD within the EU
Measures to prevent the spread of CWD within the EU would require the assumption that the
disease is already present in some part of the EU territory and affecting one or more wild,
semidomesticated or farmed cervid populations. At the time of writing this opinion, this is unknown.
Measures to prevent disease spread would be very different depending on the distribution, prevalence
and the population at the time and place in which it was detected in the EU for the first time. No
specific programme of preventive measures can therefore be proposed.
As stated in Section 3.3.1, acquiring reliable distribution and prevalence data early on may improve
the efficacy of future CWD control efforts. The uncertainties associated with the limited knowledge of
the situation of CWD in the concerned countries could render any of the recommended measures
inadequate or insufficient. Moreover, strategies to prevent the introduction and/or the spread of CWD
must be based on a combination of measures. It is also important to emphasise the fact that the
experience in North America shows that once CWD is well established and has become endemic in the
cervid population and the environment, elimination is considered unattainable.
However, some measures listed below are intended to contain (limit the geographic extent of a
focus) and/or to control/suppress (actively stabilise or reduce infection rates in an affected herd or
population) CWD in a region or country where the disease is present. The list is not exhaustive and
measures should be applied according to the circumstances, as described above, and in addition to the
ones already mentioned aimed to prevent the introduction of CWD into the EU.
• Measures to reduce transmission by minimising animal-to-animal contact and lowering
population densities include:
– Forbid baiting and supplementary feeding of wild cervids.
– Forbid use of lick blocks.
– Non-specific cull: partial or total depopulation of captive, semidomesticated and wild
cervids in infected areas.
– General, non-selective reduction in wild population by: increasing harvest permits, and/or
extending hunting season or changing the harvest season (it should be species-specific).
– Selective culling: selective, preferential or planned removal of cervids in infected areas,
defined using geographical or any other criterion.
– Trace cervid movements from infected farms (at least 5 years prior to the identification of
CWD) and/or epidemiologically linked farms in order to apply surveillance and control
measures. This measure is only applicable to farmed cervids.
• Implement awareness campaigns to educate herders, hunters and other stakeholders about
the disease, impact, epidemiology and risk factors measures in place, consequences, safe and
appropriate disposal of PPE and carcase trimmings, among others.
• Ban the movement of dead cervids to feed wildlife and to use them as baits for hunting or
viewing, unless they have been tested, and found negative, prior to movement.
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• Ensure appropriate disposal of carcasses and parts (offal) of hunted animals, animal
by-products from slaughtered animals, clinical suspects, found dead, etc., even if not tested or
not official clinical suspects.
• Develop a contingency plan, including specific measures to be enforced in premises under
quarantine, and any other measures considered by the competent authority to be applied in
infected farms and management zones around them (to be defined by the competent
authority).
• Additional specific measures to prevent the spread of CWD within Norway:
– Avoid the movement of silage and feed, harvested or produced using plants originating in
counties where CWD has been detected, to other counties of Norway and abroad.
– Avoid lichen removal from counties where CWD has been detected.
5. Further recommendations
• Review the design of the surveillance system after 1 year of implementation
• Conduct a RA to estimate the likelihood of introduction of CWD into the EU. Surveillance would
be better designed and risk mitigation measures would be better tailored should the outputs of
such a RA be available.
• Collect data on population size, geographical distribution, spatial subdivision and density for
each cervid species in the concerned countries, concurrent with the implementation of the
proposed surveillance system. Such data would facilitate the design of future surveillance
activities and the analysis and interpretation of surveillance data.
• Implement an individual identification system and record-keeping requirements for farmed and
semidomesticated cervids.
• Set up a fit-for-purpose data collection system for the surveillance system, allowing for the
following minimal set of epidemiological data to be collected, including: species, age, sex,
geographical location (coordinates or postal code), body condition, target group, sample type,
management type (farmed, wild, semi), primary sampling unit and farm code if farmed.
• Characterise, by strain typing, all positive cases detected by surveillance.
• Archive representative tissue samples from all positive cases detected by surveillance for future
analysis and comparison.
• Genotype all cervids tested positive by surveillance and all or a representative subset of cervids
tested negative by surveillance in order to generate information on the PRNP gene in European
cervid populations, and collate data regarding the probable susceptibility or resistance of these
species to CWD.
• Consider the implementation of similar surveillance programmes to the one proposed here in
other MS not explicitly considered in this opinion.
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Appendix A – Additional information provided in the mandate
A.1. Current measures
The main provisions in the TSE Regulation currently applicable to CWD based on the preceding
scientific opinions can be summarised as follows:
• passive surveillance is mandatory also for cervids, as ‘any animal suspected of being infected by
a TSE shall be either placed under an official movement restriction until the results of a clinical
and epidemiological examination carried out by the competent authority are known, or killed for
laboratory examination under official control’ (Article 12(1) of Regulation (EC) No 999/2001);
• on a voluntary basis, the Member States may carry out additional TSE surveillance in cervids
(Part III of Chapter A of Annex III to Regulation (EC) No 999/2001);
• all parts of the body of a cervid positive for TSE must be sent to disposal as category 1
materials in accordance with the Animal By-Products Regulation 10 (Article 13.1.(a) of
Regulation (EC) No 999/2001);
• TSE-positive cases in cervids must be notified to the Commission and the Member States
(Article 11 of Regulation (EC) No 999/2001);
• in the EU, the feeding to cervids of proteins derived from animals is prohibited, with the
exception of milk and milk products, eggs and egg products, hydrolysed proteins from
non-ruminants or from ruminant hides and skins, gelatine and collagen from non-ruminants
(Article 7 and Annex IV to Regulation (EC) No 999/2001);
• at import into the EU, an attestation is required for meat and meat products from wild and
farmed cervids coming from the USA or Canada (Chapter F of Annex IX to Regulation (EC)
No 999/2001), confirming that the products:
– exclude the offal and spinal cord,
– are derived from animals tested for CWD with negative results, and
– are derived from animals which do not come from a herd (for farmed animals) or a region
(for wild animals) where CWD has been confirmed or officially suspected.
In addition, in accordance with Regulation (EU) No 206/2010, the import into the EU of live cervids
from the USA and Canada is prohibited.
The conditions for imports into the EU of certain animal by-products derived from cervid materials
can be summarised as follows:
• The import of unprocessed urine for hunting lures is prohibited when derived from farmed
cervids. The import of processed urine from farmed animals is subject to treatment
requirements laid down in the ABP Regulations. The import of urine from wild cervids is out of
the scope of the EU ABP Regulations.
• The import of pet food containing cervid materials and of products derived from cervids
(including PAP) and destined for the manufacturing of pet food is permitted provided that the
requirements of the ABP Regulations are met. Raw materials must be derived from cervids
slaughtered for human consumption.
• For hides and skins, blood and blood products, animal by-products intended for technical uses,
rendered fats, gelatine and collagen, hydrolysed protein, di- and tricalcium phosphate, fat
derivatives, the principle followed in the ABP Regulations can be summarised as follows:
– For raw products: imports are permitted only from third countries that are authorised for
the import of fresh meat of cervids;
– For processed products derived from cervids: imports are permitted from all third
countries listed in the Part I of Annex II to Regulation (EC) No 206/2010;
– For fully processed game trophies or hides and skins: imports are permitted from any third
countries.
A.2. Import data
During the last 10 years, no meat of cervids was imported in the EU or EEA countries from the
USA. Import data from Canada are in Table A.1 (extracted from TRACES).
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The following information has been providing on surveillance after 2010:
Table A.1: Cervid meat imported from Canada into the EU



























BE: Belgium; DE: Germany; CH: Switzerland; FR: France.




2011 2012 2013 2014 2015
Farmed reindeer Rangifer tarandus tarandus Slaughtered – – – – –
Fallen stock 2 1 4 13 3
Forest reindeer Rangifer tarandus fennicus Found dead(a) – – – – –
Moose Alces alces Hunted – – – – –
Found dead 4 9 3 3 6
White-tailed
deer
Odocoileus virginianus Found dead 1 2 5 3 4
Hunted – – – – –
Roe deer Capreolus capreolus Found dead 1 2 2 2 –
Slaughtered – – – – –
Fallow deer Dama dama Found dead – – – 1 1
Red deer Cervus elaphus Slaughtered 1 – – – –
TOTAL 9 14 14 22 14
(a): Found dead = sick, road kill or found dead.
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Poland, the Netherland, Lithuania, the United Kingdom Portugal: no TSE test in cervids in the
period 2011–2015.
Sweden: one clinical suspicion in a reindeer in the period 2011–2015.
Table A.3: Number of species of cervids tested in Denmark for the period 2011–2015






Table A.4: Number of species of cervids tested in Norway for the period 2010–2015
Year
Farmed deer Wild deer
Total
Fallow deer Red deer Reindeer Moose Red deer Musk Reindeer Roe deer
2010 – 2 – 13 3 4 2 17 41
2011 – 11 1 11 2 – 1 12 38
2012 3 6 – 5 4 – – 3 21
2013 1 4 – 1 – – – 4 10
2014 – 2 – 5 2 – – 1 10
2015 – 3 – 4 1 – – 8 19
Table A.5: Number of species of cervids tested in Latvia for the period 2010–2015
Year Number of cervids
2011 –
2012 –
2013 2 (Alces alces)
2014 –
2015 2
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